{"id":5789,"date":"2024-09-18T09:00:00","date_gmt":"2024-09-18T03:30:00","guid":{"rendered":"https:\/\/www.srotefeatures.in\/srote\/?p=5789"},"modified":"2024-09-12T11:47:43","modified_gmt":"2024-09-12T06:17:43","slug":"%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f","status":"publish","type":"post","link":"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/","title":{"rendered":"\u0924\u0948\u092f\u093e\u0930\u0936\u0941\u0926\u093e \u0926\u0935\u093e \u092e\u093f\u0936\u094d\u0930\u0923\u094b\u0902 (\u090f\u092b\u0921\u0940\u0938\u0940) \u092a\u0930 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0915\u094d\u092f\u094b\u0902?"},"content":{"rendered":"\n

\u090f\u0938. \u0936\u094d\u0930\u0940\u0928\u093f\u0935\u093e\u0938\u0928<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

\u0915\u0947\u0902\u0926\u094d\u0930 \u0938\u0930\u0915\u093e\u0930 \u0928\u0947 \u0939\u093e\u0932 \u0939\u0940 \u092e\u0947\u0902 156 \u0928\u093f\u092f\u0924 \u0916\u0941\u0930\u093e\u0915 \u0938\u0902\u092f\u094b\u091c\u0928\u094b\u0902 (\u092b\u093f\u0915\u094d\u0938\u094d\u0921 \u0921\u094b\u091c\u093c \u0915\u0949\u092e\u094d\u092c\u093f\u0928\u0947\u0936\u0928 \u0921\u094d\u0930\u0917\u094d\u0938 \u092f\u093e \u090f\u092b\u0921\u0940\u0938\u0940) \u0915\u0947 \u0909\u0924\u094d\u092a\u093e\u0926\u0928, \u0935\u093f\u092a\u0923\u0928 \u0914\u0930 \u0935\u093f\u0924\u0930\u0923 \u092a\u0930 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0932\u0917\u093e\u092f\u093e \u0939\u0948\u0964 \u0935\u093f\u0936\u0947\u0937\u091c\u094d\u091e \u0938\u092e\u093f\u0924\u093f\u092f\u094b\u0902 \u0915\u0947 \u092e\u0941\u0924\u093e\u092c\u093f\u0915 \u092f\u0947 \u090f\u092b\u0921\u0940\u0938\u0940 \u092c\u0947\u0924\u0941\u0915\u0947 \u0939\u0948\u0902 \u092f\u093e \u091a\u093f\u0915\u093f\u0924\u094d\u0938\u093e \u0915\u0940 \u0926\u0943\u0937\u094d\u091f\u093f \u0938\u0947 \u0907\u0928\u0915\u093e \u0915\u094b\u0908 \u0914\u091a\u093f\u0924\u094d\u092f \u0928\u0939\u0940\u0902 \u0939\u0948\u0902 (medical necessity)\u0964 <\/p>\n\n\n\n

\u0932\u0947\u0915\u093f\u0928 \u0910\u0938\u093e \u092a\u0939\u0932\u0940 \u092c\u093e\u0930 \u0928\u0939\u0940\u0902 \u0939\u0941\u0906 \u0939\u0948\u0964 \u091c\u0942\u0928 2023 \u092e\u0947\u0902 \u0915\u0947\u0902\u0926\u094d\u0930 \u0938\u0930\u0915\u093e\u0930 \u0928\u0947 14 \u090f\u092b\u0921\u0940\u0938\u0940 \u0914\u0937\u0927\u093f\u092f\u094b\u0902 \u092a\u0930 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0932\u0917\u093e\u092f\u093e \u0925\u093e (drug bans)\u0964 \u0914\u0930 2016 \u0938\u0947 \u0905\u092c \u0924\u0915 \u0932\u0917\u092d\u0917 500 \u090f\u092b\u0921\u0940\u0938\u0940 \u0914\u0937\u0927\u093f\u092f\u094b\u0902 \u092a\u0930 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0932\u0917\u093e\u092f\u093e \u091c\u093e \u091a\u0941\u0915\u093e \u0939\u0948\u0964 \u092f\u0947 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0915\u094d\u092f\u094b\u0902? <\/p>\n\n\n\n

\u0932\u0947\u0915\u093f\u0928 \u092a\u0939\u0932\u0947 \u092f\u0939 \u0926\u0947\u0916\u0924\u0947 \u0939\u0948\u0902 \u0915\u093f \u090f\u092b\u0921\u0940\u0938\u0940 \u0914\u0937\u0927\u093f\u092f\u093e\u0902 \u092f\u093e \u0928\u093f\u092f\u0924 \u0916\u0941\u0930\u093e\u0915 \u0938\u0902\u092f\u094b\u091c\u0928 \u0915\u094d\u092f\u093e \u0939\u0948\u0902? \u0928\u093f\u092f\u0924 \u0916\u0941\u0930\u093e\u0915 \u0938\u0902\u092f\u094b\u091c\u0928 (\u090f\u092b\u0921\u0940\u0938\u0940) \u0910\u0938\u0940 \u0914\u0937\u0927\u093f\u092f\u093e\u0902 \u0939\u094b\u0924\u0940 \u0939\u0948\u0902 \u091c\u093f\u0938\u092e\u0947\u0902 \u090f\u0915 \u0917\u094b\u0932\u0940, \u0915\u0948\u092a\u094d\u0938\u0942\u0932, \u092f\u093e \u0936\u0949\u091f \u092e\u0947\u0902 \u0926\u094b \u092f\u093e \u0926\u094b \u0938\u0947 \u0905\u0927\u093f\u0915 \u0914\u0937\u0927\u093f\u092f\u093e\u0902 \u092f\u093e \u0926\u0935\u093e\u090f\u0902 \u090f\u0915 \u0938\u093e\u0925 \u0939\u094b\u0924\u0940 \u0939\u0948\u0902 (fixed dose combinations)\u0964 \u0909\u0926\u093e\u0939\u0930\u0923 \u0915\u0947 \u0932\u093f\u090f, \u092a\u0948\u0930\u093e\u0938\u093f\u091f\u093e\u092e\u0949\u0932 \u0914\u0930 \u0907\u092c\u0941\u092a\u094d\u0930\u094b\u092b\u0947\u0928\u0964 \u092f\u0926\u093f \u092a\u0948\u0930\u093e\u0938\u093f\u091f\u093e\u092e\u0949\u0932 \u0914\u0930 \u0907\u092c\u0941\u092a\u094d\u0930\u094b\u092b\u0947\u0928 \u0915\u094b \u092e\u093f\u0932\u093e\u0924\u0947 \u0939\u0948\u0902 \u0924\u094b \u092f\u0939 \u090f\u0915 \u090f\u092b\u0921\u0940\u0938\u0940 \u0939\u0948, \u092f\u0939 \u0938\u0902\u092f\u094b\u091c\u0928 \u0915\u0949\u092e\u094d\u092c\u093f\u092b\u094d\u0932\u0947\u092e \u092e\u0947\u0902 \u0939\u094b\u0924\u093e \u0939\u0948 (Combiflam)\u0964 \u0915\u093f\u0938\u0940 \u0938\u092e\u092f \u092e\u0947\u0902 \u0939\u092e\u093e\u0930\u0947 \u092f\u0939\u093e\u0902 \u090f\u0915-\u090f\u0915 \u090f\u092b\u0921\u0940\u0938\u0940 \u092e\u0947\u0902 10-10 \u0926\u0935\u093e\u0913\u0902 \u0915\u093e \u092e\u093f\u0936\u094d\u0930\u0923 \u0939\u0941\u0906 \u0915\u0930\u0924\u093e \u0925\u093e \u0914\u0930 \u0906\u091c \u092d\u0940 \u0910\u0938\u0940 \u0926\u0935\u093e\u0907\u092f\u093e\u0902 \u092a\u094d\u0930\u091a\u0932\u0928 \u092e\u0947\u0902 \u0939\u0948, \u091c\u093f\u0928\u0915\u0940 \u0935\u093e\u0938\u094d\u0924\u0935 \u092e\u0947\u0902 \u0915\u094b\u0908 \u091c\u093c\u0930\u0942\u0930\u0924 \u0928 \u0924\u092c \u0925\u0940 \u0914\u0930 \u0928 \u0906\u091c \u0939\u0948 (medicinal needs)\u0964 <\/p>\n\n\n\n

\u090f\u0915 \u0938\u0935\u093e\u0932 \u092f\u0939 \u0909\u0920\u0924\u093e \u0939\u0948 \u0915\u093f \u0938\u093f\u0930\u094d\u092b \u092d\u093e\u0930\u0924 \u092e\u0947\u0902 \u0907\u0924\u0928\u0947 \u092c\u0947\u0924\u0941\u0915\u0947 \u0926\u0935\u093e \u0938\u0902\u092f\u094b\u091c\u0928 \u0926\u0947\u0916\u0928\u0947 \u0915\u094b \u0915\u094d\u092f\u094b\u0902 \u092e\u093f\u0932\u0924\u0947 \u0939\u0948\u0902? \u0926\u0930\u0905\u0938\u0932 70, 80 \u0914\u0930 90 \u0915\u0947 \u0926\u0936\u0915 \u092e\u0947\u0902, \u092d\u093e\u0930\u0924 \u0935\u093f\u0936\u094d\u0935 \u0915\u0947 (\u0915\u092e \u0938\u0947 \u0915\u092e \u0935\u093f\u0915\u093e\u0938\u0936\u0940\u0932 \u0935\u093f\u0936\u094d\u0935 \u0915\u0947) \u0932\u093f\u090f \u2018\u0926\u0935\u093e \u0938\u092a\u094d\u0932\u093e\u092f\u0930\u2019 \u092c\u0928\u0928\u0947 \u0915\u0940 \u0930\u093e\u0939 \u092a\u0930 \u0925\u093e \u0914\u0930 \u0906\u091c \u092d\u0940 \u0939\u0948 \u0914\u0930 \u0916\u0942\u092c \u092a\u094d\u0930\u0917\u0924\u093f \u0915\u0930 \u0930\u0939\u093e \u0925\u093e (pharmaceutical supplier)\u0964 \u0909\u0938 \u0938\u092e\u092f \u0926\u0947\u0936 \u092e\u0947\u0902 \u0914\u0937\u0927\u093f \u0928\u093f\u0930\u094d\u092e\u093e\u0923 \u0915\u0947 \u0915\u093e\u092f\u0926\u0947-\u0915\u093e\u0928\u0942\u0928 \u0907\u0924\u0928\u0947 \u0938\u0916\u094d\u0924 \u0928\u0939\u0940\u0902 \u0925\u0947 \u091c\u093f\u0924\u0928\u0947 \u0938\u0916\u094d\u0924 \u0939\u094b\u0928\u0947 \u091a\u093e\u0939\u093f\u090f \u0925\u0947\u0964 \u0926\u0935\u093e \u0928\u093f\u0930\u094d\u092e\u093e\u0924\u093e\u0913\u0902 \u0928\u0947 \u0907\u0938\u0915\u093e \u092b\u093e\u092f\u0926\u093e \u0909\u0920\u093e\u092f\u093e\u0964 \u0915\u0948\u0938\u0947? <\/p>\n\n\n\n

\u092d\u093e\u0930\u0924 \u092e\u0947\u0902 \u0928\u0908 \u0926\u0935\u093e \u0915\u094b \u092c\u093e\u091c\u093c\u093e\u0930 \u092e\u0947\u0902 \u0932\u093e\u0928\u0947 \u0915\u0940 \u0938\u093e\u092e\u093e\u0928\u094d\u092f \u092a\u094d\u0930\u0915\u094d\u0930\u093f\u092f\u093e \u092f\u0939 \u0939\u0948 \u0915\u093f \u0915\u093f\u0938\u0940 \u092d\u0940 \u0928\u0908 \u0914\u0937\u0927\u093f \u0915\u0947 \u0932\u093f\u090f \u0906\u0935\u0947\u0926\u0928 \u0914\u0930 \u091c\u093c\u0930\u0942\u0930\u0940 \u091c\u093e\u0928\u0915\u093e\u0930\u0940 \u0915\u0947\u0902\u0926\u094d\u0930 \u0938\u0930\u0915\u093e\u0930 \u0915\u0947 \u0938\u0902\u0917\u0920\u0928, \u0938\u0947\u0902\u091f\u094d\u0930\u0932 \u0921\u094d\u0930\u0917 \u0938\u094d\u091f\u0948\u0902\u0921\u0930\u094d\u0921\u094d\u0938 \u0915\u0902\u091f\u094d\u0930\u094b\u0932 \u0911\u0930\u094d\u0917\u0928\u093e\u0907\u091c\u093c\u0947\u0936\u0928 (CDSCO), \u0915\u094b \u0926\u093f\u092f\u093e \u091c\u093e\u0924\u093e \u0939\u0948 (CDSCO approval)\u0964 CDSCO \u0915\u0940 \u0935\u093f\u0936\u0947\u0937\u091c\u094d\u091e \u0938\u092e\u093f\u0924\u093f \u0907\u0938 \u092a\u0930 \u0935\u093f\u091a\u093e\u0930 \u0915\u0930\u0915\u0947 \u0907\u0938\u0947 \u092e\u0902\u091c\u093c\u0942\u0930 (\u092f\u093e \u0928\u093e\u092e\u0902\u091c\u093c\u0942\u0930) \u0915\u0930\u0924\u0940 \u0939\u0948\u0964 CDSCO \u0938\u0947 \u092e\u0902\u091c\u093c\u0942\u0930\u0940 \u092e\u093f\u0932 \u091c\u093e\u0928\u0947 \u0915\u0947 \u092c\u093e\u0926, \u0926\u0935\u093e \u0928\u093f\u0930\u094d\u092e\u093e\u0924\u093e \u0915\u094b \u0907\u0938 \u0926\u0935\u093e \u0928\u093f\u0930\u094d\u092e\u093e\u0923 \u0915\u0947 \u0932\u093f\u090f \u0930\u093e\u091c\u094d\u092f \u0932\u093e\u092f\u0938\u0947\u0902\u0938\u093f\u0902\u0917 \u0905\u0927\u093f\u0915\u093e\u0930\u0940 \u0938\u0947 \u0932\u093e\u092f\u0938\u0947\u0902\u0938 \u092a\u094d\u0930\u093e\u092a\u094d\u0924 \u0915\u0930\u0928\u093e \u0939\u094b\u0924\u093e \u0939\u0948 (state licensing authority)\u0964 \u0932\u093e\u092f\u0938\u0947\u0902\u0938 \u092e\u093f\u0932\u0928\u0947 \u0915\u0947 \u092c\u093e\u0926 \u0939\u0940 \u0909\u0938\u0915\u093e \u0909\u0924\u094d\u092a\u093e\u0926\u0928 \u0936\u0941\u0930\u0942 \u0915\u093f\u092f\u093e \u091c\u093e \u0938\u0915\u0924\u093e \u0939\u0948\u0964<\/p>\n\n\n\n

\u0905\u092c, 70-80-90 \u0915\u0947 \u0926\u0936\u0915 \u092e\u0947\u0902 \u0939\u0941\u0906 \u092f\u0939 \u0915\u093f \u0915\u0908 \u0928\u093f\u0930\u094d\u092e\u093e\u0924\u093e \u0915\u0947\u0902\u0926\u094d\u0930\u0940\u092f \u092a\u094d\u0930\u093e\u0927\u093f\u0915\u0930\u0923\u094b\u0902 \u0938\u0947 \u0907\u0928\u0915\u0940 \u091c\u093e\u0902\u091a-\u092a\u0930\u0916 \u0915\u0930\u093e\u0928\u0947 \u0914\u0930 \u092e\u0902\u091c\u093c\u0942\u0930\u0940 \u0932\u0947\u0928\u0947 \u0915\u0940 \u091c\u093c\u0939\u092e\u0924 \u0909\u0920\u093e\u0928\u0947 \u0915\u0940 \u092c\u091c\u093e\u092f \u0932\u093e\u0907\u0938\u0947\u0902\u0938 \u0915\u0947 \u0932\u093f\u090f \u0938\u0940\u0927\u0947 \u0932\u093e\u092f\u0938\u0947\u0902\u0938\u093f\u0902\u0917 \u092a\u094d\u0930\u093e\u0927\u093f\u0915\u0930\u0923 \u0915\u0947 \u092a\u093e\u0938 \u091a\u0932\u0947 \u091c\u093e\u0924\u0947 \u0925\u0947 (regulatory authorities)\u0964 \u0935\u093e\u0938\u094d\u0924\u0935 \u092e\u0947\u0902, \u0930\u093e\u091c\u094d\u092f \u0932\u093e\u092f\u0938\u0947\u0902\u0938\u093f\u0902\u0917 \u092a\u094d\u0930\u093e\u0927\u093f\u0915\u0930\u0923 \u0915\u094b \u092a\u0942\u091b\u0928\u093e \u091a\u093e\u0939\u093f\u090f \u0925\u093e \u0915\u093f \u0915\u094d\u092f\u093e \u0906\u092a\u0915\u094b \u0915\u0947\u0902\u0926\u094d\u0930\u0940\u092f \u092a\u094d\u0930\u093e\u0927\u093f\u0915\u0930\u0923 \u0938\u0947 \u092e\u0902\u091c\u093c\u0942\u0930\u0940 \u092e\u093f\u0932 \u0917\u0908 \u0939\u0948 (central approval)? \u0932\u0947\u0915\u093f\u0928 \u0935\u0947 \u0928\u0939\u0940\u0902 \u092a\u0942\u091b\u0924\u0947 \u0925\u0947\u0964 \u0924\u094b, \u0928\u093f\u0930\u094d\u092e\u093e\u0924\u093e\u0913\u0902 \u0928\u0947 \u0907\u0938 \u0922\u0940\u0932\u0947-\u0922\u093e\u0932\u0947 \u0930\u0935\u0948\u092f\u0947 \u0915\u093e \u092b\u093e\u092f\u0926\u093e \u0909\u0920\u093e\u092f\u093e \u0914\u0930 \u0905\u092a\u0928\u0940 \u092e\u0928\u091a\u093e\u0939\u0940 \u0914\u0937\u0927\u093f\u092f\u094b\u0902 \u0915\u093e \u0928\u093f\u0930\u094d\u092e\u093e\u0923 \u0915\u093f\u092f\u093e (manufacturing practices)\u0964 \u0914\u0930 \u0907\u0938 \u0924\u0930\u0939 \u091c\u093e\u0902\u091a-\u092a\u0930\u0916 \u0915\u0947 \u0905\u092d\u093e\u0935 \u092e\u0947\u0902 \u0915\u0908 \u092c\u0947\u0924\u0941\u0915\u0940 \u0914\u0930 \u092c\u093f\u0928\u093e \u0915\u093f\u0938\u0940 \u0914\u091a\u093f\u0924\u094d\u092f \u0915\u0940 \u0926\u0935\u093e\u090f\u0902 \u092c\u093e\u091c\u093c\u093e\u0930 \u092e\u0947\u0902 \u0906 \u0917\u0908\u0902 (market regulations)\u0964 <\/p>\n\n\n\n

\u091a\u0942\u0902\u0915\u093f \u0924\u092c \u092d\u093e\u0930\u0924\u0940\u092f \u092b\u093e\u0930\u094d\u092e\u093e \u0909\u0926\u094d\u092f\u094b\u0917 \u0916\u0942\u092c \u092b\u0932-\u092b\u0942\u0932 \u0930\u0939\u093e \u0925\u093e, \u091c\u094b \u0905\u092d\u0940 \u092d\u0940 \u0909\u0924\u094d\u0924\u0930\u094b\u0924\u094d\u0924\u0930 \u092c\u0922\u093c \u0939\u0940 \u0930\u0939\u093e \u0939\u0948 (Indian pharmaceutical industry), \u0907\u0938\u0932\u093f\u090f \u0907\u0924\u0928\u0940 \u0938\u093e\u0930\u0940 \u0914\u0937\u0927\u093f\u092f\u093e\u0902 \u092c\u093e\u091c\u093c\u093e\u0930 \u092e\u0947\u0902 \u0932\u093e\u0928\u0947 \u0915\u094b \u090f\u0915 \u091c\u0936\u094d\u0928 \u0915\u0940 \u0924\u0930\u0939 \u0926\u0947\u0916\u093e \u0917\u092f\u093e\u0964 \u0914\u0930 \u0907\u0938 \u0924\u0930\u0939 \u0926\u0935\u093e \u0928\u093f\u0930\u094d\u092e\u093e\u0924\u093e \u0905\u0927\u093f\u0915\u093e\u0927\u093f\u0915 \u0914\u0937\u0927\u093f\u092f\u093e\u0902 \u092c\u093e\u091c\u093c\u093e\u0930 \u092e\u0947\u0902 \u0932\u093e\u0924\u0947 \u0917\u090f (market expansion)\u0964 <\/p>\n\n\n\n

\u0935\u0947 \u0938\u093f\u0930\u094d\u092b \u0936\u0949\u0930\u094d\u091f\u0915\u091f \u0938\u0947 \u0905\u0924\u094d\u092f\u0927\u093f\u0915 \u0914\u0937\u0927\u093f\u092f\u093e\u0902 \u0928\u0939\u0940\u0902 \u0932\u093e\u090f, \u092c\u0932\u094d\u0915\u093f \u0909\u0928\u094d\u0939\u094b\u0902\u0928\u0947 \u0915\u0908 \u0935\u093f\u0935\u093e\u0926\u093e\u0938\u094d\u092a\u0926 \u0926\u093e\u0935\u0947 \u092d\u0940 \u0915\u093f\u090f\u0964 \u091c\u0948\u0938\u0947 \u090f\u092b\u0921\u0940\u0938\u0940 \u092e\u0947\u0902 \u0906\u092a\u0915\u094b \u090f\u0915 \u0938\u0947 \u0905\u0927\u093f\u0915 \u0910\u0938\u0940 \u0926\u0935\u093e\u0907\u092f\u093e\u0902 \u092e\u093f\u0932\u0947\u0902\u0917\u0940 \u091c\u094b \u0906\u092a\u0915\u0947 \u0932\u093f\u090f \u092c\u0947\u0939\u0924\u0930 \u0939\u0948 (product claims)\u0964 \u0932\u0947\u0915\u093f\u0928 \u0915\u093f\u0938\u0940 \u0928\u0947 \u0909\u0928 \u0926\u093e\u0935\u094b\u0902 \u092a\u0930 \u0938\u0935\u093e\u0932 \u0928\u0939\u0940\u0902 \u0909\u0920\u093e\u090f\u0964 \u0914\u0930 \u0924\u094b \u0914\u0930, (\u0915\u0941\u091b \u092d\u0932\u0947 \u0932\u094b\u0917\u094b\u0902 \u0915\u094b \u091b\u094b\u0921\u093c\u0915\u0930) \u0921\u0949\u0915\u094d\u091f\u0930\u094b\u0902, \u091a\u093f\u0915\u093f\u0924\u094d\u0938\u093e \u092a\u0947\u0936\u0947\u0935\u0930\u094b\u0902, \u0907\u0902\u0921\u093f\u092f\u0928 \u092e\u0947\u0921\u093f\u0915\u0932 \u090f\u0938\u094b\u0938\u093f\u090f\u0936\u0928 \u091c\u0948\u0938\u0947 \u091c\u093c\u093f\u092e\u094d\u092e\u0947\u0926\u093e\u0930 \u0938\u092e\u0942\u0939\u094b\u0902 \u0924\u0915 \u0928\u0947 \u0907\u0928 \u092a\u0930 \u0938\u0935\u093e\u0932 \u0928\u0939\u0940\u0902 \u0909\u0920\u093e\u090f (medical professionals, Indian Medical Association)\u0964 <\/p>\n\n\n\n

\u092c\u093e\u091c\u093c\u093e\u0930 \u092e\u0947\u0902 \u090f\u092b\u0921\u0940\u0938\u0940 \u0915\u0940 \u092c\u093e\u0922\u093c \u0932\u093e\u0928\u0947 \u092e\u0947\u0902 \u090f\u0915 \u0915\u093e\u0930\u0923 \u0915\u0940\u092e\u0924 \u092d\u0940 \u0939\u0948 (drug pricing)\u0964 \u0926\u0930\u0905\u0938\u0932, \u090f\u092b\u0921\u0940\u0938\u0940 \u0914\u0937\u0927\u093f\u092f\u093e\u0902 \u092c\u0928\u093e\u0915\u0930 \u0928\u093f\u0930\u094d\u092e\u093e\u0924\u093e (\u090f\u0915\u0932) \u0914\u0937\u0927\u093f\u092f\u094b\u0902 \u0915\u0947 \u0932\u093f\u090f \u0938\u0930\u0915\u093e\u0930 \u0926\u094d\u0935\u093e\u0930\u093e \u0928\u093f\u0930\u094d\u0927\u093e\u0930\u093f\u0924 \u0905\u0927\u093f\u0915\u0924\u092e \u092e\u0942\u0932\u094d\u092f \u0938\u0947 \u092c\u091a \u0928\u093f\u0915\u0932\u0924\u0947 \u0939\u0948\u0902 (price control regulations)\u0964 \u092b\u093f\u0932\u0939\u093e\u0932, \u092d\u093e\u0930\u0924 \u092e\u0947\u0902 \u0930\u093e\u0937\u094d\u091f\u094d\u0930\u0940\u092f \u091c\u093c\u0930\u0942\u0930\u0940 \u0926\u0935\u093e \u0938\u0942\u091a\u0940 (NLEM) \u092e\u0947\u0902 \u0936\u093e\u092e\u093f\u0932 384 \u0926\u0935\u093e\u0907\u092f\u093e\u0902 \u092e\u0942\u0932\u094d\u092f \u0928\u093f\u092f\u0902\u0924\u094d\u0930\u0923 \u0915\u0947 \u0926\u093e\u092f\u0930\u0947 \u092e\u0947\u0902 \u0939\u0948\u0902 (NLEM list)\u0964 \u0932\u0947\u0915\u093f\u0928 80-90 \u0915\u0947 \u0926\u0936\u0915 \u092e\u0947\u0902, \u092c\u0939\u0941\u0924 \u0915\u092e \u0914\u0937\u0927\u093f\u092f\u093e\u0902 \u092e\u0942\u0932\u094d\u092f \u0928\u093f\u092f\u0902\u0924\u094d\u0930\u0923 \u0915\u0947 \u0905\u0927\u0940\u0928 \u0925\u0940\u0902; \u092c\u093e\u091c\u093c\u093e\u0930 \u092e\u0947\u0902 \u092e\u094c\u091c\u0942\u0926 \u0915\u0941\u0932 \u0914\u0937\u0927\u093f\u092f\u094b\u0902 \u092e\u0947\u0902 \u0938\u0947 \u0932\u0917\u092d\u0917 5-10 \u092a\u094d\u0930\u0924\u093f\u0936\u0924\u0964 \u0906\u091c \u092d\u0940 \u092f\u0939 \u0905\u0927\u093f\u0915 \u0938\u0947 \u0905\u0927\u093f\u0915 20 \u092a\u094d\u0930\u0924\u093f\u0936\u0924 \u0939\u0948 (market share, drug pricing controls)\u0964 <\/p>\n\n\n\n

\u0905\u092c \u092f\u0926\u093f \u0928\u093f\u0930\u094d\u092e\u093e\u0924\u093e NLEM \u092e\u0947\u0902 \u0936\u093e\u092e\u093f\u0932 \u0914\u0937\u0927\u093f \u0915\u0947 \u092e\u0942\u0932\u094d\u092f \u0928\u093f\u092f\u0902\u0924\u094d\u0930\u0923 \u0938\u0947 \u092c\u091a\u0928\u093e \u091a\u093e\u0939\u0924\u0947 \u0939\u0948\u0902 \u0924\u094b \u0930\u093e\u0938\u094d\u0924\u093e \u0906\u0938\u093e\u0928 \u0939\u0948; \u0914\u0937\u0927\u093f \u092e\u0947\u0902 \u0915\u0948\u092b\u0940\u0928 \u091c\u0948\u0938\u0940 \u0915\u094b\u0908 \u091a\u0940\u091c\u093c \u091c\u094b\u0921\u093c\u0915\u0930 \u0907\u0938\u0915\u0947 \u0928\u093f\u0930\u094d\u092e\u093e\u0923 \u0915\u0947 \u0932\u093f\u090f \u0905\u0928\u0941\u092e\u094b\u0926\u0928 \u0932\u0947 \u0932\u093f\u092f\u093e \u091c\u093e\u090f (exemptions from price control)\u0964 \u092f\u0939 \u092e\u093f\u0936\u094d\u0930\u0923 \u0926\u0935\u093e \u092e\u0942\u0932\u094d\u092f \u0928\u093f\u092f\u0902\u0924\u094d\u0930\u0923 \u0938\u0947 \u092c\u093e\u0939\u0930 \u0939\u094b \u091c\u093e\u090f\u0917\u0940 (price control exemptions)\u0964 <\/p>\n\n\n\n

\u0907\u0938\u0915\u0947 \u0905\u0932\u093e\u0935\u093e, \u092f\u0926\u093f \u092a\u0948\u0930\u093e\u0938\u093f\u091f\u093e\u092e\u0949\u0932 \u0915\u0940 500 \u092e\u093f.\u0917\u094d\u0930\u093e. \u0915\u0940 \u0917\u094b\u0932\u0940 NLEM \u0938\u0942\u091a\u0940 \u092e\u0947\u0902 \u0939\u0948, \u0924\u094b \u0928\u093f\u0930\u094d\u092e\u093e\u0924\u093e \u0907\u0938\u0915\u093e \u092a\u0948\u0930\u093e\u0938\u093f\u091f\u093e\u092e\u0949\u0932 501 \u092e\u093f.\u0917\u094d\u0930\u093e. \u0938\u0902\u0938\u094d\u0915\u0930\u0923 \u092c\u0928\u093e\u0915\u0930 \u092e\u0942\u0932\u094d\u092f \u0928\u093f\u092f\u0902\u0924\u094d\u0930\u0923 \u0938\u0947 \u092c\u093e\u0939\u0930 \u0928\u093f\u0915\u0932 \u0938\u0915\u0924\u0947 \u0939\u0948\u0902 (dosage variations)\u0964 \u0915\u094d\u092f\u094b\u0902\u0915\u093f \u092e\u0942\u0932\u094d\u092f \u0928\u093f\u092f\u0902\u0924\u094d\u0930\u0923 \u0938\u093f\u0930\u094d\u092b \u0914\u0937\u0927\u093f\u092f\u094b\u0902 \u0915\u0940 \u0935\u093f\u0936\u0947\u0937 \u0936\u0915\u094d\u0924\u093f \u092a\u0930 \u0932\u093e\u0917\u0942 \u0939\u094b\u0924\u093e \u0939\u0948\u0964 \u0907\u0938\u0915\u093e \u0935\u093e\u0938\u094d\u0924\u0935\u093f\u0915 \u0909\u0926\u093e\u0939\u0930\u0923 \u0939\u0948 \u092c\u093e\u091c\u093c\u093e\u0930 \u092e\u0947\u0902 \u092e\u094c\u091c\u0942\u0926 \u092a\u0948\u0930\u093e\u0938\u093f\u091f\u093e\u092e\u0949\u0932 1000 \u092e\u093f.\u0917\u094d\u0930\u093e. (high dosage forms)\u0964 \u092a\u0948\u0930\u093e\u0938\u093f\u091f\u093e\u092e\u0949\u0932 \u0915\u093e \u092f\u0939 \u0905\u0928\u0941\u091a\u093f\u0924 \u0921\u094b\u091c\u093c \u0939\u0948, \u0932\u0947\u0915\u093f\u0928 \u0907\u0938\u0947 \u092e\u0902\u091c\u093c\u0942\u0930\u0940 \u092e\u093f\u0932\u0940 \u0939\u0941\u0908 \u0939\u0948, \u092c\u093e\u091c\u093c\u093e\u0930 \u092e\u0947\u0902 \u0909\u092a\u0932\u092c\u094d\u0927 \u0939\u0948 \u0914\u0930 \u092f\u0939 \u092e\u0942\u0932\u094d\u092f \u0928\u093f\u092f\u0902\u0924\u094d\u0930\u0923 \u0938\u0947 \u092c\u093e\u0939\u0930 \u0939\u0948 (market availability, price control). \u0924\u094b, \u092c\u0938 \u0916\u0941\u0930\u093e\u0915 \u092c\u0926\u0932\u0915\u0930, \u092f\u093e \u090f\u0915 \u092f\u093e \u0905\u0927\u093f\u0915 \u0938\u093e\u092e\u0917\u094d\u0930\u0940 \u091c\u094b\u0921\u093c\u0915\u0930 \u0928\u093f\u0930\u094d\u092e\u093e\u0924\u093e \u0907\u0938\u0947 \u090f\u0915 \u0928\u0908 \u0926\u0935\u093e \u0915\u0939\u0924\u0947 \u0939\u0948\u0902 \u0914\u0930 \u092e\u0942\u0932\u094d\u092f \u0928\u093f\u092f\u0902\u0924\u094d\u0930\u0923 \u0938\u0947 \u092c\u091a \u0928\u093f\u0915\u0932\u0924\u0947 \u0939\u0948\u0902 (regulatory loopholes, price control evasion)\u0964<\/p>\n\n\n\n

\u0938\u093f\u0930\u094d\u092b \u0907\u0924\u0928\u093e \u0939\u0940 \u0928\u0939\u0940\u0902, \u0926\u0935\u093e \u0928\u093f\u0930\u094d\u092e\u093e\u0924\u093e \u0905\u092a\u0928\u0940 \u092e\u0939\u0902\u0917\u0940 \u0926\u0935\u093e\u0907\u092f\u094b\u0902 \u0915\u094b \u0916\u0930\u0940\u0926\u0928\u0947 \u0915\u0947 \u0932\u093f\u090f \u0932\u094b\u0917\u094b\u0902 \u0915\u094b \u092c\u0947\u0924\u0941\u0915\u0947 \u0924\u0930\u094d\u0915 \u0926\u0947\u0915\u0930 \u092c\u0930\u0917\u0932\u093e\u0924\u0947 \u092d\u0940 \u0939\u0948\u0902 (marketing tactics)\u0964 \u091c\u0948\u0938\u0947 \u0935\u0947 \u0907\u0928 \u092e\u0939\u0902\u0917\u0940 \u0926\u0935\u093e\u0913\u0902 \u0915\u094b \u092f\u0939 \u0915\u0939\u0915\u0930 \u092c\u0947\u091a\u0924\u0947 \u0939\u0948\u0902 \u0915\u093f \u0939\u092e \u0906\u092a\u0915\u094b \u090f\u0915 \u0938\u0947 \u0905\u0927\u093f\u0915 \u0938\u092e\u0938\u094d\u092f\u093e\u0913\u0902 \u0915\u0947 \u0932\u093f\u090f \u090f\u0915 \u0938\u093e\u0925 \u0926\u094b \u0926\u0935\u093e\u090f\u0902 \u0926\u0947 \u0930\u0939\u0947 \u0939\u0948\u0902 (product benefits, combination drugs)\u0964 <\/p>\n\n\n\n

\u0938\u0935\u093e\u0932 \u0909\u0920\u0924\u093e \u0939\u0948 \u0915\u093f \u0906\u0916\u093f\u0930 \u0915\u094d\u092f\u093e \u090f\u092b\u0921\u0940\u0938\u0940 \u0915\u092d\u0940 \u0909\u092a\u092f\u0941\u0915\u094d\u0924 \u092d\u0940 \u0939\u094b\u0924\u0947 \u0939\u0948\u0902 \u092f\u093e \u0939\u092e\u0947\u0936\u093e \u092c\u0947\u0924\u0941\u0915\u0947 \u0939\u094b\u0924\u0947 \u0939\u0948\u0902 (appropriateness of FDCs)? \u0910\u0938\u093e \u0928\u0939\u0940\u0902 \u0939\u0948\u0902\u0964 \u0915\u0941\u091b \u092e\u093e\u092e\u0932\u094b\u0902 \u092e\u0947\u0902 \u090f\u092b\u0921\u0940\u0938\u0940 \u0909\u092a\u092f\u094b\u0917\u0940 \u0939\u094b\u0924\u0947 \u0939\u0948\u0902\u0964 \u091c\u0948\u0938\u0947 \u0924\u092c \u091c\u092c \u0909\u0928\u092e\u0947\u0902 \u0909\u092a\u0938\u094d\u0925\u093f\u0924 \u0918\u091f\u0915 \u0932\u0917\u092d\u0917 \u0939\u092e\u0947\u0936\u093e \u0938\u093e\u0925-\u0938\u093e\u0925 \u0926\u0947\u0928\u093e \u091c\u093c\u0930\u0942\u0930\u0940 \u0939\u094b\u0924\u093e \u0939\u0948 (functional combinations)\u0964 \u091c\u0940\u0935\u0928 \u0930\u0915\u094d\u0937\u0915 \u0918\u094b\u0932 (\u0913\u0906\u0930\u090f\u0938) \u090f\u0915 \u0909\u0926\u093e\u0939\u0930\u0923 \u0939\u0948 (ORS solution)\u0964 \u0907\u0938\u092e\u0947\u0902 \u092e\u093f\u0932\u093e\u090f \u0917\u090f \u0918\u091f\u0915 \u0921\u0940\u0939\u093e\u092f\u0921\u094d\u0930\u0947\u0936\u0928 \u0915\u092e \u0915\u0930\u0928\u0947, \u0926\u0938\u094d\u0924 \u0915\u0940 \u0930\u094b\u0915\u0925\u093e\u092e \u0935\u0917\u0948\u0930\u0939 \u092e\u0947\u0902 \u091c\u093c\u0930\u0942\u0930\u0940 \u0939\u0948\u0902\u0964 \u0907\u0938\u0915\u0947 \u0905\u0932\u093e\u0935\u093e, \u0915\u0908 \u0918\u091f\u0915 \u090f\u0915-\u0926\u0942\u0938\u0930\u0947 \u0915\u0940 \u0915\u094d\u0930\u093f\u092f\u093e \u092e\u0947\u0902 \u092e\u0926\u0926\u0917\u093e\u0930 \u0939\u094b\u0924\u0947 \u0939\u0948\u0902\u0964 \u0907\u0938 \u0938\u094d\u0925\u093f\u0924\u093f \u092e\u0947\u0902 \u0907\u0928\u094d\u0939\u0947\u0902 \u0938\u093f\u0928\u0930\u094d\u091c\u093f\u0938\u094d\u091f\u093f\u0915 \u0915\u0939\u0924\u0947 \u0939\u0948\u0902 (synergistic effects)\u0964 \u092f\u0926\u093f \u0915\u093f\u0938\u0940 \u090f\u092b\u0921\u0940\u0938\u0940 \u0915\u0947 \u0918\u091f\u0915 \u0938\u093f\u0928\u0930\u094d\u091c\u093f\u0938\u094d\u091f\u093f\u0915 \u0939\u0948\u0902 \u0924\u094b \u0909\u0938\u0947 \u0924\u0930\u094d\u0915\u0938\u0902\u0917\u0924 \u0915\u0939\u093e \u091c\u093e \u0938\u0915\u0924\u093e \u0939\u0948 (rational use of FDCs)\u0964 <\/p>\n\n\n\n

\u092b\u093f\u0930, \u090f\u092b\u0921\u0940\u0938\u0940 \u0915\u0947 \u0918\u091f\u0915\u094b\u0902 \u0915\u0940 \u091c\u0948\u0935-\u0909\u092a\u0932\u092c\u094d\u0927\u0924\u093e (bioavailability) \u092a\u0930 \u0935\u093f\u091a\u093e\u0930 \u0915\u0930\u0928\u093e \u0939\u094b\u0917\u093e\u0964 \u092f\u093e\u0928\u0940 \u092f\u0926\u093f \u0926\u094b \u092f\u093e \u0926\u094b \u0938\u0947 \u0905\u0927\u093f\u0915 \u0914\u0937\u0927\u093f\u092f\u093e\u0902 \u0938\u092e\u094d\u092e\u093f\u0932\u093f\u0924 \u0930\u0942\u092a \u092e\u0947\u0902 \u092a\u0930\u094b\u0938\u0940 \u091c\u093e \u0930\u0939\u0940 \u0939\u0948\u0902 \u0924\u094b \u0909\u0928\u094d\u0939\u0947\u0902 \u0932\u0917\u092d\u0917 \u090f\u0915 \u0939\u0940 \u0938\u092e\u092f \u092e\u0947\u0902 \u0930\u0915\u094d\u0924 \u092e\u0947\u0902 \u091a\u0930\u092e \u092a\u0930 \u0939\u094b\u0928\u093e \u091a\u093e\u0939\u093f\u090f (pharmacokinetics)\u0964 \u0932\u0947\u0915\u093f\u0928 \u0905\u0927\u093f\u0915\u093e\u0902\u0936 \u090f\u092b\u0921\u0940\u0938\u0940 \u092e\u0947\u0902 \u0936\u093e\u092e\u093f\u0932 \u0926\u0935\u093e\u0907\u092f\u094b\u0902 \u0915\u0947 \u0938\u093e\u0925 \u0910\u0938\u093e \u0928\u0939\u0940\u0902 \u0939\u0948\u0964 \u0907\u0938\u0932\u093f\u090f, \u0910\u0938\u0947 \u092e\u093f\u0936\u094d\u0930\u0923 \u0924\u0930\u094d\u0915\u0939\u0940\u0928 \u0939\u0948\u0902 (inappropriate combinations)\u0964 <\/p>\n\n\n\n

\u0935\u093e\u0938\u094d\u0924\u0935 \u092e\u0947\u0902, NLEM, 2022 \u092e\u0947\u0902 \u0924\u0915\u0930\u0940\u092c\u0928 384 \u091c\u093c\u0930\u0942\u0930\u0940 \u0926\u0935\u093e\u0907\u092f\u094b\u0902 \u092e\u0947\u0902 \u0938\u0947 \u0915\u0947\u0935\u0932 22 \u090f\u092b\u0921\u0940\u0938\u0940 \u0939\u0940 \u0907\u0938 \u0938\u0942\u091a\u0940 \u092e\u0947\u0902 \u0939\u0948 (essential medicines list, NLEM)\u0964 \u091a\u0942\u0902\u0915\u093f \u092f\u0947 NLEM \u092e\u0947\u0902 \u0939\u0948, \u0907\u0938\u0932\u093f\u090f \u0907\u0928 22 \u090f\u092b\u0921\u0940\u0938\u0940 \u0915\u094b \u0924\u0930\u094d\u0915\u0938\u0902\u0917\u0924 \u092e\u093e\u0928\u093e \u091c\u093e \u0938\u0915\u0924\u093e \u0939\u0948 (approved FDCs)\u0964 <\/p>\n\n\n\n

\u090f\u0915 \u0905\u0928\u0941\u092e\u093e\u0928 \u0939\u0948 \u0915\u093f \u0932\u0917\u092d\u0917 800-900 \u0905\u0923\u0941 \u0914\u0937\u0927\u0940\u092f \u0909\u092a\u092f\u094b\u0917 \u0915\u0947 \u0932\u093f\u090f \u0909\u092a\u0932\u092c\u094d\u0927 \u0939\u0948\u0902 (drug molecules)\u0964 \u0907\u0928\u092e\u0947\u0902 \u0938\u0947 \u0915\u0908 \u0914\u0937\u0927\u093f\u092f\u094b\u0902 \u0915\u0947 \u0928\u093f\u0930\u094d\u092e\u093e\u0923 \u0906\u0926\u093f \u0938\u092e\u094d\u092c\u0902\u0927\u0940 \u091c\u093e\u0928\u0915\u093e\u0930\u0940 \u090f\u0935\u0902 \u0907\u0928\u0915\u0940 \u0917\u0941\u0923\u0935\u0924\u094d\u0924\u093e \u0915\u0940 \u091c\u093e\u0902\u091a \u0915\u0947 \u0924\u0930\u0940\u0915\u0947 \u092d\u093e\u0930\u0924\u0940\u092f \u092b\u093e\u0930\u094d\u092e\u093e\u0915\u094b\u092a\u093f\u092f\u093e \u0935 \u0905\u0928\u094d\u092f \u092c\u0947\u0939\u0924\u0930 \u0928\u093f\u092f\u0902\u0924\u094d\u0930\u093f\u0924 \u0926\u0947\u0936\u094b\u0902 \u0915\u0947 \u092b\u093e\u0930\u094d\u092e\u093e\u0915\u094b\u092a\u093f\u092f\u093e \u092e\u0947\u0902 \u0935\u0930\u094d\u0923\u093f\u0924 \u0939\u0948\u0902 (pharmacopoeia standards)\u0964 \u090f\u0915\u0932 \u0918\u091f\u0915 \u0914\u0937\u0927\u093f\u092f\u094b\u0902 \u0915\u0940 \u0917\u0941\u0923\u0935\u0924\u094d\u0924\u093e \u092f\u093e \u0915\u093e\u0930\u0917\u0930\u0924\u093e \u092a\u0930\u0916 \u0915\u0947 \u0932\u093f\u090f \u0905\u0927\u093f\u0915\u0924\u092e 20 \u092e\u093e\u0928\u0926\u0902\u0921 \u0939\u0948\u0902 \u091c\u093f\u0928 \u092a\u0930 \u0916\u0930\u093e \u0909\u0924\u0930\u0928\u093e \u0906\u0935\u0936\u094d\u092f\u0915 \u0939\u0948\u0964 \u0932\u0947\u0915\u093f\u0928 \u092f\u0926\u093f \u0926\u094b \u092f\u093e \u0905\u0927\u093f\u0915 \u0918\u091f\u0915\u094b\u0902 \u0915\u093e \u0938\u0902\u092f\u094b\u091c\u0928 \u0915\u0930 \u0926\u093f\u092f\u093e \u091c\u093e\u0924\u093e \u0939\u0948, \u0924\u094b \u0939\u092e\u093e\u0930\u0947 \u092a\u093e\u0938 \u0907\u0928 \u0938\u0902\u092f\u094b\u091c\u0928\u094b\u0902 \u0915\u0940 \u0917\u0941\u0923\u0935\u0924\u094d\u0924\u093e \u092f\u093e \u0915\u093e\u0930\u0917\u0930\u0924\u093e \u0915\u094b \u091c\u093e\u0902\u091a\u0928\u0947-\u092a\u0930\u0916\u0928\u0947 \u0915\u0947 \u0915\u094b\u0908 \u092e\u093e\u0928\u0915 \u092e\u093e\u0928\u0926\u0902\u0921 \u0928\u0939\u0940\u0902 \u0939\u0948 (combination standards, quality assessment)\u0964 \u0915\u094d\u092f\u094b\u0902\u0915\u093f \u0907\u0928\u0915\u093e \u092b\u093e\u0930\u094d\u092e\u093e\u0915\u094b\u092a\u093f\u092f\u093e \u092e\u0947\u0902 \u0915\u094b\u0908 \u0909\u0932\u094d\u0932\u0947\u0916 \u0928\u0939\u0940\u0902 \u0939\u0948\u0964 \u0928\u0924\u0940\u091c\u093e, \u090f\u092b\u0921\u0940\u0938\u0940 \u0915\u0947 \u0928\u093f\u0930\u094d\u092e\u093e\u0924\u093e \u0939\u0940 \u0939\u092e\u0947\u0902 \u0938\u0902\u092f\u094b\u091c\u0928 \u0915\u0947 \u092a\u0930\u0940\u0915\u094d\u0937\u0923 \u0915\u0947 \u0924\u0930\u0940\u0915\u0947 \u092c\u0924\u093e\u0924\u0947 \u0939\u0948\u0902 (manufacturer claims)\u0964 \u0907\u0928 \u092a\u0930 \u0928\u093f\u0917\u0930\u093e\u0928\u0940 \u0930\u0916\u0928\u0947 \u0935\u093e\u0932\u0947 \u0935\u093f\u0936\u0947\u0937\u091c\u094d\u091e\u094b\u0902 \u0915\u0947 \u092a\u093e\u0938 \u0907\u0928 \u0924\u0930\u0940\u0915\u094b\u0902 \u0915\u094b \u091c\u093e\u0902\u091a\u0928\u0947 \u0915\u0947 \u0932\u093f\u090f \u0928 \u0924\u094b \u0938\u092e\u092f \u0939\u094b\u0924\u093e \u0939\u0948 \u0914\u0930 \u0928 \u0939\u0940 \u0938\u0941\u0935\u093f\u0927\u093e (regulatory oversight)\u0964 \u0928\u0924\u0940\u091c\u0924\u0928, \u0907\u0928 \u090f\u092b\u0921\u0940\u0938\u0940 \u0914\u0937\u0927\u093f\u092f\u094b\u0902 \u0915\u0940 \u0917\u0941\u0923\u0935\u0924\u094d\u0924\u093e \u0914\u0930 \u0915\u093e\u0930\u0917\u0930\u0924\u093e \u0915\u0947 \u092c\u093e\u0930\u0947 \u092e\u0947\u0902 \u0915\u0941\u091b \u0915\u0939\u0928\u093e \u091c\u091f\u093f\u0932 \u092e\u093e\u092e\u0932\u093e \u0939\u094b \u091c\u093e\u0924\u093e \u0939\u0948 (complexity in assessment)\u0964 \u0914\u0930 \u092b\u093f\u0930, \u0915\u093f\u0938\u0940 \u0928\u0947 \u0907\u0928 \u092a\u0930 \u092a\u0930\u094d\u092f\u093e\u092a\u094d\u0924 \u0936\u094b\u0927 \u092d\u0940 \u0928\u0939\u0940\u0902 \u0915\u093f\u090f \u0939\u0948\u0902\u0964 NLEM \u092e\u0947\u0902 \u0936\u093e\u092e\u093f\u0932 22 \u0938\u0902\u092f\u094b\u091c\u0928\u094b\u0902 \u092a\u0930 \u0939\u0940 \u092a\u0930\u094d\u092f\u093e\u092a\u094d\u0924 \u0936\u094b\u0927 \u0939\u0941\u090f \u0939\u0948\u0902 (research gaps, studies on FDCs)\u0964<\/p>\n\n\n\n

\u0909\u092a\u0930\u094b\u0915\u094d\u0924 \u0915\u093e\u0930\u0923\u094b\u0902 \u0938\u0947 \u092c\u093e\u091c\u093c\u093e\u0930 \u092e\u0947\u0902 \u0924\u0930\u094d\u0915\u0939\u0940\u0928 \u090f\u092b\u0921\u0940\u0938\u0940 \u0915\u0940 \u092d\u0930\u092e\u093e\u0930 \u0939\u0948 (excess of irrational FDCs)\u0964 \u0907\u0928\u092e\u0947\u0902 \u090f\u0902\u091f\u0940\u092c\u093e\u092f\u094b\u091f\u093f\u0915\u094d\u0938, \u0926\u0930\u094d\u0926\u0928\u093f\u0935\u093e\u0930\u0915 \u092f\u093e \u092e\u0927\u0941\u092e\u0947\u0939-\u0930\u094b\u0927\u0940 \u0907\u0924\u094d\u092f\u093e\u0926\u093f \u0915\u0947 \u0938\u0902\u092f\u094b\u091c\u0928 \u092d\u0940 \u092e\u094c\u091c\u0942\u0926 \u0939\u0948\u0902 (antibiotic combinations, painkillers, antidiabetic drugs)\u0964 \u091c\u0948\u0938\u0947, \u090f\u0902\u091f\u0940\u092c\u093e\u092f\u094b\u091f\u093f\u0915 \u0914\u0930 \u0926\u0930\u094d\u0926\u0928\u093f\u0935\u093e\u0930\u0915, \u090f\u0902\u091f\u0940\u092c\u093e\u092f\u094b\u091f\u093f\u0915 \u0914\u0930 \u090f\u0902\u091f\u0940-\u0915\u094b\u0932\u0947\u0938\u094d\u091f\u094d\u0930\u0949\u0932, \u090f\u0902\u091f\u0940\u092c\u093e\u092f\u094b\u091f\u093f\u0915 \u0914\u0930 \u090f\u0902\u091f\u0940-\u092c\u094d\u0932\u0921\u092a\u094d\u0930\u0947\u0936\u0930, \u0907\u0924\u094d\u092f\u093e\u0926\u093f (antibiotic and painkiller, antibiotic and anti-cholesterol, antibiotic and anti-hypertension)\u0964 \u092f\u0947 \u090f\u092b\u0921\u0940\u0938\u0940 \u0905\u0932\u0917-\u0905\u0932\u0917 \u0909\u092a\u091a\u093e\u0930\u093e\u0924\u094d\u092e\u0915 \u0935\u0930\u094d\u0917 \u0915\u0940 \u0914\u0937\u0927\u093f\u092f\u094b\u0902 \u0915\u0947 \u092e\u093f\u0936\u094d\u0930\u0923 \u0939\u0948\u0902 (therapeutic classes of drugs).<\/p>\n\n\n\n

\u0939\u094b\u0924\u093e \u092f\u0939 \u0939\u0948 \u0915\u093f (\u090f\u092b\u0921\u0940\u0938\u0940 \u0915\u0940 \u092d\u0930\u092e\u093e\u0930 \u0915\u0947 \u0915\u093e\u0930\u0923) \u0915\u0908 \u092c\u093e\u0930 \u0915\u094b\u0908 \u0930\u094b\u0917\u0940 \u0926\u094b, \u0924\u0940\u0928 \u092f\u093e \u0926\u0938 \u0926\u0935\u093e\u0913\u0902 \u0915\u0947 \u0938\u0902\u092f\u094b\u091c\u0928 \u0935\u093e\u0932\u0940 \u0914\u0937\u0927\u093f \u0916\u093e \u0930\u0939\u093e \u0939\u094b\u0924\u093e \u0939\u0948, \u091c\u092c\u0915\u093f \u0909\u0938\u0947 \u0938\u093f\u0930\u094d\u092b \u090f\u0915 \u0939\u0940 \u0914\u0937\u0927\u093f \u0915\u0940 \u091c\u093c\u0930\u0942\u0930\u0924 \u0925\u0940 (excessive drug combinations)\u0964 \u091c\u0948\u0938\u0947, \u0932\u094b\u0917 \u0926\u0930\u094d\u0926 \u0915\u0947 \u0932\u093f\u090f \u0915\u0949\u092e\u094d\u092c\u093f\u092b\u094d\u0932\u0947\u092e (\u092a\u0948\u0930\u093e\u0938\u093f\u091f\u093e\u092e\u0949\u0932 \u0914\u0930 \u0907\u092c\u0941\u092a\u094d\u0930\u094b\u092b\u0947\u0928 \u0915\u093e \u0938\u0902\u092f\u094b\u091c\u0928) \u0932\u0947\u0924\u0947 \u0939\u0948\u0902 (Combiflam, paracetamol and ibuprofen combination)\u0964 \u091c\u092c\u0915\u093f \u0926\u0930\u094d\u0926 \u0915\u0947 \u0932\u093f\u090f \u0906\u092a\u0915\u094b \u0938\u093f\u0930\u094d\u092b \u092a\u0948\u0930\u093e\u0938\u093f\u091f\u093e\u092e\u0949\u0932 \u0915\u0940 \u091c\u093c\u0930\u0942\u0930\u0924 \u0939\u0948, \u0907\u092c\u0941\u092a\u094d\u0930\u094b\u092b\u0947\u0928 \u0915\u0940 \u0928\u0939\u0940\u0902 \u0939\u0948 (need for only paracetamol)\u0964 \u0907\u0938\u0932\u093f\u090f, \u091c\u092c \u0906\u092a \u0926\u0930\u094d\u0926 \u092e\u0947\u0902 \u0915\u0949\u092e\u094d\u092c\u093f\u092b\u094d\u0932\u0947\u092e \u0932\u0947 \u0930\u0939\u0947 \u0939\u0948\u0902, \u0924\u094b \u0906\u092a\u0915\u094b \u0907\u092c\u0941\u092a\u094d\u0930\u094b\u092b\u0947\u0928 \u0915\u0947 \u092a\u094d\u0930\u0924\u093f\u0915\u0942\u0932 \u092a\u094d\u0930\u092d\u093e\u0935 \u0939\u094b\u0924\u0947 \u0939\u0948\u0902 (adverse effects of ibuprofen)\u0964 \u0907\u0938\u0940 \u0924\u0930\u0939, \u091c\u092c \u0906\u092a \u090f\u092b\u0921\u0940\u0938\u0940 \u0915\u0947 \u091a\u0932\u0924\u0947 \u092c\u0947\u0935\u091c\u0939 \u092a\u0948\u0930\u093e\u0938\u093f\u091f\u093e\u092e\u0949\u0932 \u0916\u093e\u0924\u0947 \u0939\u0948\u0902 \u0924\u094b \u0932\u0940\u0935\u0930 \u0915\u0940 \u0915\u094d\u0937\u0924\u093f \u0914\u0930 \u0905\u0928\u094d\u092f \u0938\u092e\u0938\u094d\u092f\u093e\u090f\u0902 \u0939\u094b \u0938\u0915\u0924\u0940 \u0939\u0948\u0902 (liver damage, unnecessary paracetamol intake)\u0964 \u0905\u0928\u093e\u0935\u0936\u094d\u092f\u0915 \u0930\u0942\u092a \u0938\u0947 \u091c\u093c\u094d\u092f\u093e\u0926\u093e \u0926\u0935\u093e\u090f\u0902 \u0916\u093e \u0932\u0947\u0928\u0947 \u0915\u0947 \u0905\u092a\u0928\u0947 \u0938\u093e\u0907\u0921-\u0907\u092b\u0947\u0915\u094d\u091f \u0914\u0930 \u092a\u094d\u0930\u0924\u093f\u0915\u0942\u0932 \u092a\u094d\u0930\u092d\u093e\u0935 \u0939\u094b\u0924\u0947 \u0939\u0948\u0902 (side effects, adverse reactions)\u0964 \u0907\u0938\u0932\u093f\u090f \u090f\u092b\u0921\u0940\u0938\u0940 \u0930\u094b\u0917\u0940 \u0915\u0947 \u091c\u0940\u0935\u0928 \u0915\u094b \u091c\u091f\u093f\u0932 \u092c\u0928\u093e \u0930\u0939\u0940 \u0939\u0948\u0902 (complications from FDCs)\u0964<\/p>\n\n\n\n

\u0905\u092c \u0925\u094b\u0921\u093c\u093e \u092c\u093e\u091c\u093c\u093e\u0930 \u092e\u0947\u0902 \u0907\u0928\u0915\u0940 \u092c\u093f\u0915\u094d\u0930\u0940 \u0915\u0940 \u0938\u094d\u0925\u093f\u0924\u093f \u0926\u0947\u0916\u0924\u0947 \u0939\u0948\u0902\u0964 \u090f\u0915 \u0906\u0902\u0915\u0921\u093c\u093e \u0939\u0948 \u0915\u093f \u092d\u093e\u0930\u0924 \u092e\u0947\u0902 \u0926\u0935\u093e\u0913\u0902 \u0915\u0940 \u0915\u0941\u0932 \u092c\u093f\u0915\u094d\u0930\u0940 \u0915\u093e \u0932\u0917\u092d\u0917 50 \u092a\u094d\u0930\u0924\u093f\u0936\u0924 \u090f\u092b\u0921\u0940\u0938\u0940 \u0939\u0948\u0902 \u0914\u0930 50 \u092a\u094d\u0930\u0924\u093f\u0936\u0924 \u090f\u0915\u0932 \u0918\u091f\u0915 \u0926\u0935\u093e\u090f\u0902 \u0939\u0948\u0902 (market share of FDCs and single ingredient drugs)\u0964 \u0910\u0938\u093e \u092a\u093e\u092f\u093e \u0917\u092f\u093e \u0939\u0948 \u0915\u093f \u0907\u0938 50 \u092a\u094d\u0930\u0924\u093f\u0936\u0924 \u090f\u092b\u0921\u0940\u0938\u0940 \u092e\u0947\u0902 \u0938\u0947 \u0906\u0927\u0940 \u092c\u093f\u0915\u094d\u0930\u0940 \u0924\u094b \u0924\u0930\u094d\u0915\u0938\u0902\u0917\u0924 \u090f\u092b\u0921\u0940\u0938\u0940 \u0915\u0940 \u0939\u0948 \u0914\u0930 \u0936\u0947\u0937 \u0924\u0930\u094d\u0915\u0939\u0940\u0928 \u090f\u092b\u0921\u0940\u0938\u0940 \u0915\u0940 (rational vs irrational FDCs)\u0964 \u092f\u093e\u0928\u0940 \u092c\u093e\u091c\u093c\u093e\u0930 \u092e\u0947\u0902 \u0915\u092e \u0938\u0947 \u0915\u092e 25 \u092a\u094d\u0930\u0924\u093f\u0936\u0924 \u0924\u0930\u094d\u0915\u0939\u0940\u0928 \u090f\u092b\u0921\u0940\u0938\u0940 \u092c\u093f\u0915 \u0930\u0939\u0940 \u0939\u0948\u0902 (percentage of irrational FDCs)\u3002<\/p>\n\n\n\n

\u0935\u0930\u094d\u0924\u092e\u093e\u0928 \u092e\u0947\u0902, \u092d\u093e\u0930\u0924 \u092e\u0947\u0902 \u0914\u0937\u0927\u093f\u092f\u094b\u0902 \u0915\u093e \u092c\u093e\u091c\u093c\u093e\u0930 \u0932\u0917\u092d\u0917 2 \u0932\u093e\u0916 \u0915\u0930\u094b\u0921\u093c (2 \u091f\u094d\u0930\u093f\u0932\u093f\u092f\u0928) \u0930\u0941\u092a\u090f \u0915\u093e \u0939\u0948 (pharmaceutical market size, 2 trillion INR)\u0964 \u0907\u0938\u092e\u0947\u0902 \u0938\u0947 25 \u092a\u094d\u0930\u0924\u093f\u0936\u0924 \u092f\u093e\u0928\u0940 50,000 \u0915\u0930\u094b\u0921\u093c \u0930\u0941\u092a\u092f\u0947 \u0924\u0930\u094d\u0915\u0939\u0940\u0928 \u090f\u092b\u0921\u0940\u0938\u0940 \u0915\u0940 \u0916\u092a\u0924 \u0938\u0947 \u0906\u0924\u0947 \u0939\u0948\u0902 (market value of irrational FDCs)\u0964 \u092f\u0926\u093f \u0907\u0928\u094d\u0939\u0947\u0902 \u092c\u093e\u091c\u093c\u093e\u0930 \u0938\u0947 \u0939\u091f\u093e \u0926\u093f\u092f\u093e \u0924\u094b \u091c\u093c\u093e\u0939\u093f\u0930 \u0939\u0948, \u0926\u0935\u093e \u0915\u0940 \u092c\u093f\u0915\u094d\u0930\u0940 \u092e\u0947\u0902 \u092d\u093e\u0930\u0940 \u0917\u093f\u0930\u093e\u0935\u091f \u0906\u090f\u0917\u0940 (impact on market sales)\u0964 \u092c\u093e\u091c\u093c\u093e\u0930 \u0924\u094b \u0907\u0928 \u0926\u0935\u093e\u0913\u0902 \u0915\u0947 \u0939\u091f\u093e\u0928\u0947 \u0924\u094b \u0924\u0948\u092f\u093e\u0930 \u0928\u0939\u0940\u0902 \u0939\u094b\u0917\u093e, \u0928 \u0939\u0940 \u0936\u0947\u092f\u0930\u0927\u093e\u0930\u0915 \u0915\u094d\u092f\u094b\u0902\u0915\u093f \u0909\u0928\u094d\u0939\u0947\u0902 \u0905\u092a\u0928\u0947 \u0928\u093f\u0935\u0947\u0936 \u092a\u0930 \u0930\u093f\u091f\u0930\u094d\u0928 \u091a\u093e\u0939\u093f\u090f (shareholder interests, market resistance)\u3002<\/p>\n\n\n\n

\u0924\u0930\u094d\u0915\u0939\u0940\u0928 \u090f\u092b\u0921\u0940\u0938\u0940 \u0915\u094b \u092c\u093e\u091c\u093c\u093e\u0930 \u0938\u0947 \u0939\u091f\u093e\u0928\u0947 \u0915\u0947 \u0932\u093f\u090f \u091c\u093c\u0930\u0942\u0930\u0924 \u0939\u0948 \u0938\u0930\u0915\u093e\u0930 \u0915\u0947 \u0938\u094d\u0924\u0930 \u092a\u0930 \u0909\u091a\u093f\u0924 \u0915\u093e\u0930\u094d\u0930\u0935\u093e\u0908 \u0915\u0940, \u0909\u091a\u093f\u0924 \u092a\u094d\u0930\u0915\u094d\u0930\u093f\u092f\u093e \u0905\u092a\u0928\u093e\u0928\u0947 \u0915\u0940 \u0914\u0930 \u0938\u0916\u094d\u0924 \u0928\u093f\u092f\u092e-\u0915\u093e\u0928\u0942\u0928 \u0932\u093e\u0917\u0942 \u0915\u0930\u0928\u0947 \u0915\u0940 \u0914\u0930 \u0909\u0932\u094d\u0932\u0902\u0918\u0928 \u092a\u0930 \u0938\u0916\u094d\u0924 \u0915\u093e\u0930\u094d\u0930\u0935\u093e\u0908 \u0915\u0940 (government intervention, regulatory measures, strict enforcement)\u0964 \u092f\u0926\u093f \u092a\u0939\u0932\u0947 \u0938\u0947 \u0939\u0940 \u0926\u0935\u093e\u0913\u0902 \u0915\u093e \u0928\u093f\u0930\u094d\u092e\u093e\u0923 \u0909\u091a\u093f\u0924 \u092e\u0902\u091c\u093c\u0942\u0930\u0940 \u092a\u094d\u0930\u0915\u094d\u0930\u093f\u092f\u093e \u0938\u0947 \u0917\u0941\u091c\u093c\u0930\u093e \u0939\u094b\u0924\u093e \u0914\u0930 \u0910\u0938\u093e \u0928 \u0939\u094b\u0928\u0947 \u092a\u0930 \u0915\u0902\u092a\u0928\u093f\u092f\u094b\u0902 \u092a\u0930 \u0938\u0916\u094d\u0924 \u0926\u0902\u0921 \u0932\u0917\u093e\u092f\u093e \u0917\u092f\u093e \u0939\u094b\u0924\u093e \u0924\u094b \u092f\u0939 \u0928\u094c\u092c\u0924 \u0928 \u0939\u094b\u0924\u0940 (approval process, penalties for non-compliance)\u0964 \u092c\u0938 \u0915\u0941\u091b-\u0915\u0941\u091b \u0938\u092e\u092f \u0915\u0947 \u0905\u0902\u0924\u0930\u093e\u0932 \u092e\u0947\u0902 \u0924\u0930\u094d\u0915\u0939\u0940\u0928 \u0926\u0935\u093e\u090f\u0902 \u0922\u0942\u0902\u0922\u0915\u0930 \u0909\u0928 \u092a\u0930 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0932\u0917\u093e \u0926\u093f\u092f\u093e \u091c\u093e\u0924\u093e \u0939\u0948 (ban on irrational drugs, periodic monitoring)\u0964 \u0939\u094b\u0924\u093e \u092f\u0939 \u0939\u0948 \u0915\u093f \u0926\u0935\u093e \u0915\u0902\u092a\u0928\u093f\u092f\u093e\u0902 \u0907\u0928 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927\u094b\u0902 \u0915\u094b \u0928\u093f\u0930\u0938\u094d\u0924 \u0915\u0930\u0935\u093e\u0928\u0947 \u092f\u093e \u0938\u094d\u0925\u0917\u0928 \u0906\u0926\u0947\u0936 \u0915\u0947 \u0932\u093f\u090f \u0928\u094d\u092f\u093e\u092f\u093e\u0932\u092f \u091c\u093e\u0924\u0940 \u0939\u0948\u0902 \u0914\u0930 \u0928\u094d\u092f\u093e\u092f\u093e\u0932\u092f \u0915\u0940 \u0915\u093e\u0930\u094d\u0930\u0935\u093e\u0908 \u092e\u0947\u0902 \u0938\u093e\u0932\u094b\u0902-\u0938\u093e\u0932 \u092c\u0940\u0924 \u091c\u093e\u0924\u0947 \u0939\u0948\u0902 (legal battles, court delays)\u0964 \u0924\u092c \u0924\u0915 \u092f\u0947 \u092c\u0947\u0924\u0941\u0915\u0940 \u0926\u0935\u093e\u0907\u092f\u093e\u0902 \u092c\u093e\u091c\u093c\u093e\u0930 \u092e\u0947\u0902 \u092c\u093f\u0915\u0924\u0940 \u0930\u0939\u0924\u0940 \u0939\u0948\u0902 (availability of irrational drugs in the market)\u0964 \u0926\u0930\u0905\u0938\u0932, \u0907\u0938 \u092e\u093e\u092e\u0932\u0947 \u092e\u0947\u0902 \u0914\u0937\u0927\u093f \u0928\u093f\u092f\u093e\u092e\u0915\u094b\u0902 \u0914\u0930 \u0926\u0935\u093e \u0909\u0926\u094d\u092f\u094b\u0917, \u0926\u094b\u0928\u094b\u0902 \u0915\u094b \u0926\u094b\u0937\u0940 \u092e\u093e\u0928\u093e \u091c\u093e\u0928\u093e \u091a\u093e\u0939\u093f\u090f (responsibility of regulators and pharmaceutical industry)\u0964<\/p>\n\n\n\n

\u0910\u0938\u093e \u0939\u0940 \u092e\u093e\u0930\u094d\u091a 2016 \u092e\u0947\u0902 \u0938\u094d\u0935\u093e\u0938\u094d\u0925\u094d\u092f \u090f\u0935\u0902 \u092a\u0930\u093f\u0935\u093e\u0930 \u0915\u0932\u094d\u092f\u093e\u0923 \u092e\u0902\u0924\u094d\u0930\u093e\u0932\u092f \u0926\u094d\u0935\u093e\u0930\u093e \u0928\u093f\u092f\u0941\u0915\u094d\u0924 \u0915\u094b\u0915\u0924\u0947 \u0915\u092e\u0947\u091f\u0940 \u0926\u094d\u0935\u093e\u0930\u093e 344 \u090f\u092b\u0921\u0940\u0938\u0940 \u092a\u0930 \u0932\u0917\u093e\u090f \u0917\u090f \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0915\u093e \u092e\u093e\u092e\u0932\u0947 \u092e\u0947\u0902 \u0939\u0941\u0906 \u0925\u093e (March 2016, Kokate Committee). \u0915\u094b\u0915\u0924\u0947 \u0938\u092e\u093f\u0924\u093f \u0928\u0947 \u0915\u0930\u0940\u092c 6000 \u090f\u092b\u0921\u0940\u0938\u0940 \u0915\u0940 \u091c\u093e\u0902\u091a \u0915\u0940 \u0925\u0940 (review of 6000 FDCs)\u0964 \u0938\u092e\u093f\u0924\u093f \u0928\u0947 \u0907\u0928 \u090f\u092b\u0921\u0940\u0938\u0940 \u0915\u094b \u091a\u093e\u0930 \u0936\u094d\u0930\u0947\u0923\u093f\u092f\u094b\u0902 \u092e\u0947\u0902 \u0921\u093e\u0932\u093e \u0925\u093e (categories of FDCs)\u0964 \u092a\u0939\u0932\u0940 \u0936\u094d\u0930\u0947\u0923\u0940 \u092e\u0947\u0902 344 \u090f\u092b\u0921\u0940\u0938\u0940 \u0925\u0940\u0902 \u091c\u094b \u0928\u093f\u0936\u094d\u091a\u093f\u0924 \u0930\u0942\u092a \u0938\u0947 \u0924\u0930\u094d\u0915\u0939\u0940\u0928 \u0925\u0940\u0902 \u0914\u0930 \u0907\u0928 \u092a\u0930 \u092a\u0942\u0930\u094d\u0923 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0932\u0917\u093e\u0928\u0947 \u0915\u094b \u0915\u0939\u093e \u0917\u092f\u093e \u0925\u093e (irrational FDCs, complete ban)\u0964<\/p>\n\n\n\n

\u0926\u0942\u0938\u0930\u0940 \u0936\u094d\u0930\u0947\u0923\u0940 \u092e\u0947\u0902 \u0910\u0938\u0940 \u0914\u0937\u0927\u093f\u092f\u093e\u0902 \u0925\u0940\u0902 \u091c\u093f\u0928 \u092a\u0930 \u0905\u0927\u093f\u0915 \u0921\u0948\u091f\u093e \u0915\u0940 \u0906\u0935\u0936\u094d\u092f\u0915\u0924\u093e \u0925\u0940 (more data required)\u0964 \u0914\u0930 \u0915\u0902\u092a\u0928\u093f\u092f\u094b\u0902 \u0915\u094b \u0907\u0928 \u092a\u0930 \u0905\u0927\u093f\u0915 \u0921\u0948\u091f\u093e \u092a\u094d\u0930\u0938\u094d\u0924\u0941\u0924 \u0915\u0930\u0928\u0947 \u0915\u0947 \u0932\u093f\u090f \u0938\u092e\u092f \u0926\u093f\u092f\u093e \u0917\u092f\u093e (extended deadline for data submission)\u0964 \u0924\u0940\u0938\u0930\u0940 \u0936\u094d\u0930\u0947\u0923\u0940 \u0924\u0930\u094d\u0915\u0938\u0902\u0917\u0924 \u090f\u092b\u0921\u0940\u0938\u0940 \u0915\u0940 \u0925\u0940 (rational FDCs)\u0964 \u0935\u0947 \u0909\u091a\u093f\u0924 \u0915\u093e\u0917\u091c\u093c\u0940 \u0915\u093e\u0930\u094d\u0930\u0935\u093e\u0908 \u0915\u0947 \u092c\u093e\u0926 \u0907\u0928\u0915\u093e \u0928\u093f\u0930\u094d\u092e\u093e\u0923 \u0935\u093f\u092a\u0923\u0928 \u091c\u093e\u0930\u0940 \u0930\u0916 \u0938\u0915\u0924\u0940 \u0925\u0940\u0902 (market approval with proper documentation)\u0964 \u0914\u0930 \u091a\u094c\u0925\u0940 \u0936\u094d\u0930\u0947\u0923\u0940 \u092e\u0947\u0902, \u0935\u0947 \u090f\u092b\u0921\u0940\u0938\u0940 \u0925\u0940\u0902 \u091c\u093f\u0928\u0915\u0940 \u0924\u0930\u094d\u0915\u0938\u0902\u0917\u0924\u0924\u093e \u0915\u0947 \u092c\u093e\u0930\u0947 \u092e\u0947\u0902 \u0915\u0941\u091b \u0915\u0939\u0928\u0947 \u0938\u0947 \u092a\u0939\u0932\u0947 \u0935\u093f\u092a\u0923\u0928-\u092a\u0936\u094d\u091a\u093e\u0924 \u0928\u093f\u0917\u0930\u093e\u0928\u0940, \u092a\u0930\u0940\u0915\u094d\u0937\u0923 \u0906\u0926\u093f \u0915\u0940 \u0906\u0935\u0936\u094d\u092f\u0915\u0924\u093e \u0925\u0940 (post-marketing surveillance required)\u0964<\/p>\n\n\n\n

\u0932\u0947\u0915\u093f\u0928 \u0915\u0902\u092a\u0928\u093f\u092f\u093e\u0902 \u090f\u0915\u0926\u092e \u0924\u0930\u094d\u0915\u0939\u0940\u0928 344 \u090f\u092b\u0921\u0940\u0938\u0940 \u0915\u0947 \u092e\u093e\u092e\u0932\u0947 \u092e\u0947\u0902 \u0924\u0941\u0930\u0902\u0924 \u0928\u094d\u092f\u093e\u092f\u093e\u0932\u092f \u091a\u0932\u0940 \u0917\u0908\u0902 (court cases against irrational FDCs)\u0964 \u0928\u094d\u092f\u093e\u092f\u093e\u0932\u092f \u0928\u0947 \u0938\u0930\u0915\u093e\u0930 \u0915\u094b \u0926\u094b\u092c\u093e\u0930\u093e \u091c\u093e\u0902\u091a \u0938\u092e\u093f\u0924\u093f \u092c\u0928\u093e\u0928\u0947 \u0915\u093e \u0928\u093f\u0930\u094d\u0926\u0947\u0936 \u0926\u093f\u092f\u093e \u0924\u093e\u0915\u093f \u0926\u0935\u093e \u0909\u0926\u094d\u092f\u094b\u0917 \u0915\u0940 \u0930\u093e\u092f \u092a\u0930 \u092b\u093f\u0930 \u0938\u0947 \u0935\u093f\u091a\u093e\u0930 \u0915\u093f\u092f\u093e \u091c\u093e \u0938\u0915\u0947 (court directives for re-evaluation)\u0964 \u0921\u0949. \u0928\u0940\u0932\u093f\u092e\u093e \u0915\u094d\u0937\u0940\u0930\u0938\u093e\u0917\u0930 \u0915\u0940 \u0905\u0927\u094d\u092f\u0915\u094d\u0937\u0924\u093e \u092e\u0947\u0902 \u0917\u0920\u093f\u0924 \u0907\u0938 \u0938\u092e\u093f\u0924\u093f \u0928\u0947 \u092d\u0940 \u0938\u093f\u0924\u0902\u092c\u0930 2018 \u092e\u0947\u0902 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0915\u094b \u091c\u093e\u092f\u091c\u093c \u0920\u0939\u0930\u093e\u092f\u093e (September 2018, Dr. Neelima Kshirsagar Committee)\u0964 \u0932\u0947\u0915\u093f\u0928 \u0915\u0902\u092a\u0928\u093f\u092f\u093e\u0902 \u092b\u093f\u0930 \u0938\u0947 \u0905\u0926\u093e\u0932\u0924 \u092a\u0939\u0941\u0902\u091a \u0917\u0908\u0902 (legal challenges by companies)\u0964 \u0915\u0902\u092a\u0928\u093f\u092f\u093e\u0902 \u091d\u0941\u0915\u0928\u0947 \u0915\u094b \u0924\u0948\u092f\u093e\u0930 \u0928\u0939\u0940\u0902 \u0939\u094b\u0924\u0940 \u0939\u0948\u0902, \u092d\u0932\u0947 \u0939\u0940 \u0909\u0928\u094d\u0939\u0947\u0902 \u092a\u0924\u093e \u0939\u094b\u0924\u093e \u0939\u0948 \u0915\u093f \u0926\u0935\u093e\u0913\u0902 \u092a\u0930 \u091c\u094b \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0932\u0917\u0947 \u0939\u0948\u0902 \u0935\u0947 \u090f\u0915\u0926\u092e \u0938\u0939\u0940 \u0939\u0948\u0902 (resistance to bans, valid restrictions)\u0964 \u0915\u0941\u091b \u0915\u094b \u0932\u0917\u0924\u093e \u0939\u0948 \u0924\u0930\u094d\u0915\u0939\u0940\u0928 \u090f\u092b\u0921\u0940\u0938\u0940 \u0938\u0947 \u0905\u091a\u094d\u091b\u093e \u092e\u0941\u0928\u093e\u092b\u093e \u092e\u093f\u0932\u0924\u093e \u0939\u0948 \u0907\u0938\u0947 \u0939\u093e\u0925 \u0915\u094d\u092f\u094b\u0902 \u091c\u093e\u0928\u0947 \u0926\u0947\u0902, \u0907\u0938\u0932\u093f\u090f \u0915\u0947\u0938 \u0932\u0921\u093c\u0924\u0940 \u0939\u0948\u0902 (profit from irrational FDCs, legal battles)\u0964 \u0938\u093e\u0925 \u092e\u0947\u0902 \u0935\u0915\u0940\u0932\u094b\u0902 \u0915\u094b \u0932\u093e\u092d \u0939\u094b\u0924\u093e \u0939\u0948 (benefits to lawyers)\u0964 \u092e\u0941\u0915\u0926\u092e\u093e \u091a\u0932\u0924\u093e \u0930\u0939\u0924\u093e \u0939\u0948 \u0914\u0930 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927\u093f\u0924 \u090f\u092b\u0921\u0940\u0938\u0940 \u092c\u093e\u091c\u093c\u093e\u0930 \u092e\u0947\u0902 \u092c\u093f\u0915\u0924\u0940 \u0930\u0939\u0924\u0940 \u0939\u0948\u0902 (market availability of banned FDCs)\u0964 \u092a\u094d\u0930\u0938\u0902\u0917\u0935\u0936 \u092f\u0939 \u092c\u0924\u093e\u092f\u093e \u091c\u093e \u0938\u0915\u0924\u093e \u0939\u0948 \u0915\u093f 2016 \u092e\u0947\u0902 \u0939\u093e\u0908 \u0915\u094b\u0930\u094d\u091f \u0914\u0930 2018 \u092e\u0947\u0902 \u0938\u0941\u092a\u094d\u0930\u0940\u092e \u0915\u094b\u0930\u094d\u091f \u092e\u0947\u0902 \u0907\u0928 \u0915\u0902\u092a\u0928\u093f\u092f\u094b\u0902 \u0915\u0940 \u092a\u0948\u0930\u0935\u0940 \u0926\u0947\u0936 \u0915\u0947 \u0928\u093e\u092e\u0940-\u0917\u093f\u0930\u093e\u092e\u0940 \u0935\u0915\u0940\u0932\u094b\u0902 \u0928\u0947 \u0915\u0940 \u0925\u0940 (notable lawyers in High Court and Supreme Court cases)\u0964 \u0924\u093e\u091c\u093c\u093e \u0906\u0926\u0947\u0936 \u0915\u0947 \u0938\u093f\u0932\u0938\u093f\u0932\u0947 \u092e\u0947\u0902 \u092d\u0940 \u0915\u0902\u092a\u0928\u093f\u092f\u093e\u0902 \u0915\u094b\u0930\u094d\u091f \u0938\u0947 \u0915\u0941\u091b \u0930\u093e\u0939\u0924 \u092a\u093e\u0928\u0947 \u092e\u0947\u0902 \u0938\u092b\u0932 \u0930\u0939\u0940 \u0939\u0948\u0902 (recent court relief).<\/p>\n\n\n\n

\u0915\u0941\u0932 \u092e\u093f\u0932\u093e\u0915\u0930 \u0938\u094d\u0925\u093f\u0924\u093f \u092f\u0939 \u0939\u0948 \u0915\u093f \u092d\u093e\u0930\u0924 \u092e\u0947\u0902 \u0928\u093f\u0917\u0930\u093e\u0928\u0940 \u0935\u094d\u092f\u0935\u0938\u094d\u0925\u093e \u0905\u092a\u0930\u094d\u092f\u093e\u092a\u094d\u0924 \u0939\u0948, \u0914\u0930 \u091c\u094b \u0915\u0941\u091b \u0939\u0948 \u0909\u0938\u0915\u093e \u092a\u093e\u0932\u0928 \u0918\u091f\u093f\u092f\u093e \u0926\u0930\u094d\u091c\u0947 \u0915\u093e \u0939\u0948 (insufficient regulatory oversight, poor enforcement)\u0964 \u0914\u0930 \u0907\u0938\u0932\u093f\u090f \u0915\u0902\u092a\u0928\u093f\u092f\u093e\u0902 \u091c\u094b \u091a\u093e\u0939\u0947\u0902 \u0915\u0930 \u0930\u0939\u0940 \u0939\u0948\u0902 (industry malpractices)\u0964 \u0935\u0930\u094d\u0924\u092e\u093e\u0928 \u092e\u0947\u0902 \u0926\u0947\u0916\u0947\u0902 \u0924\u094b \u0939\u092e\u093e\u0930\u0947 \u092a\u0921\u093c\u094b\u0938\u0940 \u092e\u0941\u0932\u094d\u0915 \u092c\u093e\u0902\u0917\u094d\u0932\u093e\u0926\u0947\u0936 \u0915\u0947 \u092a\u093e\u0938 \u090f\u0915 \u0905\u091a\u094d\u091b\u0940 \u0926\u0935\u093e \u0928\u0940\u0924\u093f \u0939\u0948, \u091c\u094b \u0909\u0928\u094d\u0939\u094b\u0902\u0928\u0947 1982 \u092e\u0947\u0902 \u0932\u093e\u0917\u0942 \u0915\u0940 \u0925\u0940 (Bangladesh drug policy, 1982)\u0964 \u0909\u0928\u094d\u0939\u094b\u0902\u0928\u0947 \u092c\u0939\u0941\u0924 \u0938\u0940 \u0924\u0930\u094d\u0915\u0939\u0940\u0928 \u0926\u0935\u093e\u0907\u092f\u094b\u0902 \u0915\u094b \u0939\u091f\u093e \u0926\u093f\u092f\u093e \u0925\u093e (removal of irrational drugs in Bangladesh)\u0964 \u0935\u0939\u093e\u0902 \u0938\u093e\u092e\u093e\u0928\u094d\u092f\u0924: \u0915\u0947\u0935\u0932 \u0924\u0930\u094d\u0915\u0938\u0902\u0917\u0924 \u090f\u0915\u0932 \u0918\u091f\u0915 \u0935\u093e\u0932\u0940 \u0926\u0935\u093e\u0907\u092f\u093e\u0902 \u0939\u0940 \u0909\u092a\u0932\u092c\u094d\u0927 \u0939\u094b\u0924\u0940 \u0939\u0948\u0902 (availability of rational single-ingredient drugs)\u0964 \u0924\u094b, \u091c\u0939\u093e\u0902 \u091a\u093e\u0939 \u0939\u0948, \u0935\u0939\u093e\u0902 \u0930\u093e\u0939 \u0939\u0948\u0964(\u0938\u094d\u0930\u094b\u0924 \u092b\u0940\u091a\u0930\u094d\u0938)<\/em><\/strong><\/p>\n\n\n\n

\u0928\u094b\u091f: \u0938\u094d\u0930\u094b\u0924 \u092e\u0947\u0902 \u091b\u092a\u0947 \u0932\u0947\u0916\u094b\u0902 \u0915\u0947 \u0935\u093f\u091a\u093e\u0930 \u0932\u0947\u0916\u0915\u094b\u0902 \u0915\u0947 \u0939\u0948\u0902\u0964 \u090f\u0915\u0932\u0935\u094d\u092f \u0915\u093e \u0907\u0928\u0938\u0947 \u0938\u0939\u092e\u0924 \u0939\u094b\u0928\u093e \u0906\u0935\u0936\u094d\u092f\u0915 \u0928\u0939\u0940\u0902 \u0939\u0948\u0964
Photo Credit : https:\/\/economictimes.indiatimes.com\/thumb\/msid-51433877,width-1200,height-900,resizemode-4,imgsize-104148\/move-to-ban-fixed-dose-combinations-a-culmination-of-efforts-to-free-market-from-irrational-drugs.jpg?from=mdr<\/p>\n","protected":false},"excerpt":{"rendered":"

\u090f\u0938. \u0936\u094d\u0930\u0940\u0928\u093f\u0935\u093e\u0938\u0928 \u0915\u0947\u0902\u0926\u094d\u0930 \u0938\u0930\u0915\u093e\u0930 \u0928\u0947 \u0939\u093e\u0932 \u0939\u0940 \u092e\u0947\u0902 156 \u0928\u093f\u092f\u0924 \u0916\u0941\u0930\u093e\u0915 \u0938\u0902\u092f\u094b\u091c\u0928\u094b\u0902 (\u092b\u093f\u0915\u094d\u0938\u094d\u0921 \u0921\u094b\u091c\u093c \u0915\u0949\u092e\u094d\u092c\u093f\u0928\u0947\u0936\u0928 \u0921\u094d\u0930\u0917\u094d\u0938 \u092f\u093e \u090f\u092b\u0921\u0940\u0938\u0940) \u0915\u0947 \u0909\u0924\u094d\u092a\u093e\u0926\u0928, \u0935\u093f\u092a\u0923\u0928 \u0914\u0930 \u0935\u093f\u0924\u0930\u0923 \u092a\u0930 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0932\u0917\u093e\u092f\u093e \u0939\u0948\u0964 \u0935\u093f\u0936\u0947\u0937\u091c\u094d\u091e \u0938\u092e\u093f\u0924\u093f\u092f\u094b\u0902 \u0915\u0947 \u092e\u0941\u0924\u093e\u092c\u093f\u0915 \u092f\u0947 \u090f\u092b\u0921\u0940\u0938\u0940 \u092c\u0947\u0924\u0941\u0915\u0947 \u0939\u0948\u0902 \u092f\u093e \u091a\u093f\u0915\u093f\u0924\u094d\u0938\u093e \u0915\u0940 \u0926\u0943\u0937\u094d\u091f\u093f \u0938\u0947 \u0907\u0928\u0915\u093e \u0915\u094b\u0908 \u0914\u091a\u093f\u0924\u094d\u092f \u0928\u0939\u0940\u0902 \u0939\u0948\u0902 (medical necessity)\u0964  \u0932\u0947\u0915\u093f\u0928 \u0910\u0938\u093e \u092a\u0939\u0932\u0940 \u092c\u093e\u0930 \u0928\u0939\u0940\u0902 \u0939\u0941\u0906 \u0939\u0948\u0964 \u091c\u0942\u0928 … <\/p>\n

\u092a\u0922\u093c\u0928\u093e \u091c\u093e\u0930\u0940 \u0930\u0916\u0947\u0902 “\u0924\u0948\u092f\u093e\u0930\u0936\u0941\u0926\u093e \u0926\u0935\u093e \u092e\u093f\u0936\u094d\u0930\u0923\u094b\u0902 (\u090f\u092b\u0921\u0940\u0938\u0940) \u092a\u0930 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0915\u094d\u092f\u094b\u0902?”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-5789","post","type-post","status-publish","format-standard","hentry","category-11"],"yoast_head":"\n\u0924\u0948\u092f\u093e\u0930\u0936\u0941\u0926\u093e \u0926\u0935\u093e \u092e\u093f\u0936\u094d\u0930\u0923\u094b\u0902 (\u090f\u092b\u0921\u0940\u0938\u0940) \u092a\u0930 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0915\u094d\u092f\u094b\u0902? - \u0938\u094d\u0930\u094b\u0924<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/\u0924\u0948\u092f\u093e\u0930\u0936\u0941\u0926\u093e-\u0926\u0935\u093e-\u092e\u093f\u0936\u094d\u0930\u0923\u094b\u0902-\u090f\/\" \/>\n<meta property=\"og:locale\" content=\"hi_IN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u0924\u0948\u092f\u093e\u0930\u0936\u0941\u0926\u093e \u0926\u0935\u093e \u092e\u093f\u0936\u094d\u0930\u0923\u094b\u0902 (\u090f\u092b\u0921\u0940\u0938\u0940) \u092a\u0930 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0915\u094d\u092f\u094b\u0902? - \u0938\u094d\u0930\u094b\u0924\" \/>\n<meta property=\"og:description\" content=\"\u090f\u0938. \u0936\u094d\u0930\u0940\u0928\u093f\u0935\u093e\u0938\u0928 \u0915\u0947\u0902\u0926\u094d\u0930 \u0938\u0930\u0915\u093e\u0930 \u0928\u0947 \u0939\u093e\u0932 \u0939\u0940 \u092e\u0947\u0902 156 \u0928\u093f\u092f\u0924 \u0916\u0941\u0930\u093e\u0915 \u0938\u0902\u092f\u094b\u091c\u0928\u094b\u0902 (\u092b\u093f\u0915\u094d\u0938\u094d\u0921 \u0921\u094b\u091c\u093c \u0915\u0949\u092e\u094d\u092c\u093f\u0928\u0947\u0936\u0928 \u0921\u094d\u0930\u0917\u094d\u0938 \u092f\u093e \u090f\u092b\u0921\u0940\u0938\u0940) \u0915\u0947 \u0909\u0924\u094d\u092a\u093e\u0926\u0928, \u0935\u093f\u092a\u0923\u0928 \u0914\u0930 \u0935\u093f\u0924\u0930\u0923 \u092a\u0930 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0932\u0917\u093e\u092f\u093e \u0939\u0948\u0964 \u0935\u093f\u0936\u0947\u0937\u091c\u094d\u091e \u0938\u092e\u093f\u0924\u093f\u092f\u094b\u0902 \u0915\u0947 \u092e\u0941\u0924\u093e\u092c\u093f\u0915 \u092f\u0947 \u090f\u092b\u0921\u0940\u0938\u0940 \u092c\u0947\u0924\u0941\u0915\u0947 \u0939\u0948\u0902 \u092f\u093e \u091a\u093f\u0915\u093f\u0924\u094d\u0938\u093e \u0915\u0940 \u0926\u0943\u0937\u094d\u091f\u093f \u0938\u0947 \u0907\u0928\u0915\u093e \u0915\u094b\u0908 \u0914\u091a\u093f\u0924\u094d\u092f \u0928\u0939\u0940\u0902 \u0939\u0948\u0902 (medical necessity)\u0964  \u0932\u0947\u0915\u093f\u0928 \u0910\u0938\u093e \u092a\u0939\u0932\u0940 \u092c\u093e\u0930 \u0928\u0939\u0940\u0902 \u0939\u0941\u0906 \u0939\u0948\u0964 \u091c\u0942\u0928 … \u092a\u0922\u093c\u0928\u093e \u091c\u093e\u0930\u0940 \u0930\u0916\u0947\u0902 "\u0924\u0948\u092f\u093e\u0930\u0936\u0941\u0926\u093e \u0926\u0935\u093e \u092e\u093f\u0936\u094d\u0930\u0923\u094b\u0902 (\u090f\u092b\u0921\u0940\u0938\u0940) \u092a\u0930 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0915\u094d\u092f\u094b\u0902?"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/\u0924\u0948\u092f\u093e\u0930\u0936\u0941\u0926\u093e-\u0926\u0935\u093e-\u092e\u093f\u0936\u094d\u0930\u0923\u094b\u0902-\u090f\/\" \/>\n<meta property=\"og:site_name\" content=\"\u0938\u094d\u0930\u094b\u0924\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-18T03:30:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.srotefeatures.in\/srote\/wp-content\/uploads\/2024\/09\/FDC-1024x768.jpg\" \/>\n<meta name=\"author\" content=\"\u0938\u094d\u0930\u094b\u0924 \u092b\u0940\u091a\u0930\u094d\u0938\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u0926\u094d\u0935\u093e\u0930\u093e \u0932\u093f\u0916\u093f\u0924\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u0938\u094d\u0930\u094b\u0924 \u092b\u0940\u091a\u0930\u094d\u0938\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u0905\u0928\u0941\u092e\u093e\u0928\u093f\u0924 \u092a\u0922\u093c\u0928\u0947 \u0915\u093e \u0938\u092e\u092f\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 \u092e\u093f\u0928\u091f\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/\"},\"author\":{\"name\":\"\u0938\u094d\u0930\u094b\u0924 \u092b\u0940\u091a\u0930\u094d\u0938\",\"@id\":\"https:\/\/www.srotefeatures.in\/srote\/#\/schema\/person\/25de3014b0ad954e6489614b2246aeab\"},\"headline\":\"\u0924\u0948\u092f\u093e\u0930\u0936\u0941\u0926\u093e \u0926\u0935\u093e \u092e\u093f\u0936\u094d\u0930\u0923\u094b\u0902 (\u090f\u092b\u0921\u0940\u0938\u0940) \u092a\u0930 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0915\u094d\u092f\u094b\u0902?\",\"datePublished\":\"2024-09-18T03:30:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/\"},\"wordCount\":402,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.srotefeatures.in\/srote\/wp-content\/uploads\/2024\/09\/FDC-1024x768.jpg\",\"articleSection\":[\"\u091a\u093f\u0915\u093f\u0924\u094d\u0938\u093e \/ \u0938\u094d\u0935\u093e\u0938\u094d\u0925\u094d\u092f\"],\"inLanguage\":\"hi-IN\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/\",\"url\":\"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/\",\"name\":\"\u0924\u0948\u092f\u093e\u0930\u0936\u0941\u0926\u093e \u0926\u0935\u093e \u092e\u093f\u0936\u094d\u0930\u0923\u094b\u0902 (\u090f\u092b\u0921\u0940\u0938\u0940) \u092a\u0930 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0915\u094d\u092f\u094b\u0902? - \u0938\u094d\u0930\u094b\u0924\",\"isPartOf\":{\"@id\":\"https:\/\/www.srotefeatures.in\/srote\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.srotefeatures.in\/srote\/wp-content\/uploads\/2024\/09\/FDC-1024x768.jpg\",\"datePublished\":\"2024-09-18T03:30:00+00:00\",\"author\":{\"@id\":\"https:\/\/www.srotefeatures.in\/srote\/#\/schema\/person\/25de3014b0ad954e6489614b2246aeab\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/#breadcrumb\"},\"inLanguage\":\"hi-IN\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"hi-IN\",\"@id\":\"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/#primaryimage\",\"url\":\"https:\/\/www.srotefeatures.in\/srote\/wp-content\/uploads\/2024\/09\/FDC.jpg\",\"contentUrl\":\"https:\/\/www.srotefeatures.in\/srote\/wp-content\/uploads\/2024\/09\/FDC.jpg\",\"width\":1200,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.srotefeatures.in\/srote\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u0924\u0948\u092f\u093e\u0930\u0936\u0941\u0926\u093e \u0926\u0935\u093e \u092e\u093f\u0936\u094d\u0930\u0923\u094b\u0902 (\u090f\u092b\u0921\u0940\u0938\u0940) \u092a\u0930 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0915\u094d\u092f\u094b\u0902?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.srotefeatures.in\/srote\/#website\",\"url\":\"https:\/\/www.srotefeatures.in\/srote\/\",\"name\":\"\u0938\u094d\u0930\u094b\u0924\",\"description\":\"\u0935\u093f\u091c\u094d\u091e\u093e\u0928 \u090f\u0935\u0902 \u091f\u0947\u0915\u094d\u0928\u0949\u0932\u0949\u091c\u0940 \u092b\u0940\u091a\u0930\u094d\u0938\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.srotefeatures.in\/srote\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"hi-IN\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.srotefeatures.in\/srote\/#\/schema\/person\/25de3014b0ad954e6489614b2246aeab\",\"name\":\"\u0938\u094d\u0930\u094b\u0924 \u092b\u0940\u091a\u0930\u094d\u0938\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"hi-IN\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/91d0ee323ccbcff14465ae42297cc4877b6fe7fe3beca4cd7343428817691db2?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/91d0ee323ccbcff14465ae42297cc4877b6fe7fe3beca4cd7343428817691db2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/91d0ee323ccbcff14465ae42297cc4877b6fe7fe3beca4cd7343428817691db2?s=96&d=mm&r=g\",\"caption\":\"\u0938\u094d\u0930\u094b\u0924 \u092b\u0940\u091a\u0930\u094d\u0938\"},\"url\":\"https:\/\/www.srotefeatures.in\/srote\/author\/srote\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u0924\u0948\u092f\u093e\u0930\u0936\u0941\u0926\u093e \u0926\u0935\u093e \u092e\u093f\u0936\u094d\u0930\u0923\u094b\u0902 (\u090f\u092b\u0921\u0940\u0938\u0940) \u092a\u0930 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0915\u094d\u092f\u094b\u0902? - \u0938\u094d\u0930\u094b\u0924","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/\u0924\u0948\u092f\u093e\u0930\u0936\u0941\u0926\u093e-\u0926\u0935\u093e-\u092e\u093f\u0936\u094d\u0930\u0923\u094b\u0902-\u090f\/","og_locale":"hi_IN","og_type":"article","og_title":"\u0924\u0948\u092f\u093e\u0930\u0936\u0941\u0926\u093e \u0926\u0935\u093e \u092e\u093f\u0936\u094d\u0930\u0923\u094b\u0902 (\u090f\u092b\u0921\u0940\u0938\u0940) \u092a\u0930 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0915\u094d\u092f\u094b\u0902? - \u0938\u094d\u0930\u094b\u0924","og_description":"\u090f\u0938. \u0936\u094d\u0930\u0940\u0928\u093f\u0935\u093e\u0938\u0928 \u0915\u0947\u0902\u0926\u094d\u0930 \u0938\u0930\u0915\u093e\u0930 \u0928\u0947 \u0939\u093e\u0932 \u0939\u0940 \u092e\u0947\u0902 156 \u0928\u093f\u092f\u0924 \u0916\u0941\u0930\u093e\u0915 \u0938\u0902\u092f\u094b\u091c\u0928\u094b\u0902 (\u092b\u093f\u0915\u094d\u0938\u094d\u0921 \u0921\u094b\u091c\u093c \u0915\u0949\u092e\u094d\u092c\u093f\u0928\u0947\u0936\u0928 \u0921\u094d\u0930\u0917\u094d\u0938 \u092f\u093e \u090f\u092b\u0921\u0940\u0938\u0940) \u0915\u0947 \u0909\u0924\u094d\u092a\u093e\u0926\u0928, \u0935\u093f\u092a\u0923\u0928 \u0914\u0930 \u0935\u093f\u0924\u0930\u0923 \u092a\u0930 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0932\u0917\u093e\u092f\u093e \u0939\u0948\u0964 \u0935\u093f\u0936\u0947\u0937\u091c\u094d\u091e \u0938\u092e\u093f\u0924\u093f\u092f\u094b\u0902 \u0915\u0947 \u092e\u0941\u0924\u093e\u092c\u093f\u0915 \u092f\u0947 \u090f\u092b\u0921\u0940\u0938\u0940 \u092c\u0947\u0924\u0941\u0915\u0947 \u0939\u0948\u0902 \u092f\u093e \u091a\u093f\u0915\u093f\u0924\u094d\u0938\u093e \u0915\u0940 \u0926\u0943\u0937\u094d\u091f\u093f \u0938\u0947 \u0907\u0928\u0915\u093e \u0915\u094b\u0908 \u0914\u091a\u093f\u0924\u094d\u092f \u0928\u0939\u0940\u0902 \u0939\u0948\u0902 (medical necessity)\u0964  \u0932\u0947\u0915\u093f\u0928 \u0910\u0938\u093e \u092a\u0939\u0932\u0940 \u092c\u093e\u0930 \u0928\u0939\u0940\u0902 \u0939\u0941\u0906 \u0939\u0948\u0964 \u091c\u0942\u0928 … \u092a\u0922\u093c\u0928\u093e \u091c\u093e\u0930\u0940 \u0930\u0916\u0947\u0902 \"\u0924\u0948\u092f\u093e\u0930\u0936\u0941\u0926\u093e \u0926\u0935\u093e \u092e\u093f\u0936\u094d\u0930\u0923\u094b\u0902 (\u090f\u092b\u0921\u0940\u0938\u0940) \u092a\u0930 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0915\u094d\u092f\u094b\u0902?\"","og_url":"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/\u0924\u0948\u092f\u093e\u0930\u0936\u0941\u0926\u093e-\u0926\u0935\u093e-\u092e\u093f\u0936\u094d\u0930\u0923\u094b\u0902-\u090f\/","og_site_name":"\u0938\u094d\u0930\u094b\u0924","article_published_time":"2024-09-18T03:30:00+00:00","og_image":[{"url":"https:\/\/www.srotefeatures.in\/srote\/wp-content\/uploads\/2024\/09\/FDC-1024x768.jpg","type":"","width":"","height":""}],"author":"\u0938\u094d\u0930\u094b\u0924 \u092b\u0940\u091a\u0930\u094d\u0938","twitter_card":"summary_large_image","twitter_misc":{"\u0926\u094d\u0935\u093e\u0930\u093e \u0932\u093f\u0916\u093f\u0924":"\u0938\u094d\u0930\u094b\u0924 \u092b\u0940\u091a\u0930\u094d\u0938","\u0905\u0928\u0941\u092e\u093e\u0928\u093f\u0924 \u092a\u0922\u093c\u0928\u0947 \u0915\u093e \u0938\u092e\u092f":"2 \u092e\u093f\u0928\u091f"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/#article","isPartOf":{"@id":"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/"},"author":{"name":"\u0938\u094d\u0930\u094b\u0924 \u092b\u0940\u091a\u0930\u094d\u0938","@id":"https:\/\/www.srotefeatures.in\/srote\/#\/schema\/person\/25de3014b0ad954e6489614b2246aeab"},"headline":"\u0924\u0948\u092f\u093e\u0930\u0936\u0941\u0926\u093e \u0926\u0935\u093e \u092e\u093f\u0936\u094d\u0930\u0923\u094b\u0902 (\u090f\u092b\u0921\u0940\u0938\u0940) \u092a\u0930 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0915\u094d\u092f\u094b\u0902?","datePublished":"2024-09-18T03:30:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/"},"wordCount":402,"commentCount":0,"image":{"@id":"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/#primaryimage"},"thumbnailUrl":"https:\/\/www.srotefeatures.in\/srote\/wp-content\/uploads\/2024\/09\/FDC-1024x768.jpg","articleSection":["\u091a\u093f\u0915\u093f\u0924\u094d\u0938\u093e \/ \u0938\u094d\u0935\u093e\u0938\u094d\u0925\u094d\u092f"],"inLanguage":"hi-IN","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/","url":"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/","name":"\u0924\u0948\u092f\u093e\u0930\u0936\u0941\u0926\u093e \u0926\u0935\u093e \u092e\u093f\u0936\u094d\u0930\u0923\u094b\u0902 (\u090f\u092b\u0921\u0940\u0938\u0940) \u092a\u0930 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0915\u094d\u092f\u094b\u0902? - \u0938\u094d\u0930\u094b\u0924","isPartOf":{"@id":"https:\/\/www.srotefeatures.in\/srote\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/#primaryimage"},"image":{"@id":"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/#primaryimage"},"thumbnailUrl":"https:\/\/www.srotefeatures.in\/srote\/wp-content\/uploads\/2024\/09\/FDC-1024x768.jpg","datePublished":"2024-09-18T03:30:00+00:00","author":{"@id":"https:\/\/www.srotefeatures.in\/srote\/#\/schema\/person\/25de3014b0ad954e6489614b2246aeab"},"breadcrumb":{"@id":"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/#breadcrumb"},"inLanguage":"hi-IN","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/"]}]},{"@type":"ImageObject","inLanguage":"hi-IN","@id":"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/#primaryimage","url":"https:\/\/www.srotefeatures.in\/srote\/wp-content\/uploads\/2024\/09\/FDC.jpg","contentUrl":"https:\/\/www.srotefeatures.in\/srote\/wp-content\/uploads\/2024\/09\/FDC.jpg","width":1200,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.srotefeatures.in\/srote\/2024\/09\/%e0%a4%a4%e0%a5%88%e0%a4%af%e0%a4%be%e0%a4%b0%e0%a4%b6%e0%a5%81%e0%a4%a6%e0%a4%be-%e0%a4%a6%e0%a4%b5%e0%a4%be-%e0%a4%ae%e0%a4%bf%e0%a4%b6%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%8b%e0%a4%82-%e0%a4%8f\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.srotefeatures.in\/srote\/"},{"@type":"ListItem","position":2,"name":"\u0924\u0948\u092f\u093e\u0930\u0936\u0941\u0926\u093e \u0926\u0935\u093e \u092e\u093f\u0936\u094d\u0930\u0923\u094b\u0902 (\u090f\u092b\u0921\u0940\u0938\u0940) \u092a\u0930 \u092a\u094d\u0930\u0924\u093f\u092c\u0902\u0927 \u0915\u094d\u092f\u094b\u0902?"}]},{"@type":"WebSite","@id":"https:\/\/www.srotefeatures.in\/srote\/#website","url":"https:\/\/www.srotefeatures.in\/srote\/","name":"\u0938\u094d\u0930\u094b\u0924","description":"\u0935\u093f\u091c\u094d\u091e\u093e\u0928 \u090f\u0935\u0902 \u091f\u0947\u0915\u094d\u0928\u0949\u0932\u0949\u091c\u0940 \u092b\u0940\u091a\u0930\u094d\u0938","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.srotefeatures.in\/srote\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"hi-IN"},{"@type":"Person","@id":"https:\/\/www.srotefeatures.in\/srote\/#\/schema\/person\/25de3014b0ad954e6489614b2246aeab","name":"\u0938\u094d\u0930\u094b\u0924 \u092b\u0940\u091a\u0930\u094d\u0938","image":{"@type":"ImageObject","inLanguage":"hi-IN","@id":"https:\/\/secure.gravatar.com\/avatar\/91d0ee323ccbcff14465ae42297cc4877b6fe7fe3beca4cd7343428817691db2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/91d0ee323ccbcff14465ae42297cc4877b6fe7fe3beca4cd7343428817691db2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/91d0ee323ccbcff14465ae42297cc4877b6fe7fe3beca4cd7343428817691db2?s=96&d=mm&r=g","caption":"\u0938\u094d\u0930\u094b\u0924 \u092b\u0940\u091a\u0930\u094d\u0938"},"url":"https:\/\/www.srotefeatures.in\/srote\/author\/srote\/"}]}},"_links":{"self":[{"href":"https:\/\/www.srotefeatures.in\/srote\/wp-json\/wp\/v2\/posts\/5789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.srotefeatures.in\/srote\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.srotefeatures.in\/srote\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.srotefeatures.in\/srote\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.srotefeatures.in\/srote\/wp-json\/wp\/v2\/comments?post=5789"}],"version-history":[{"count":1,"href":"https:\/\/www.srotefeatures.in\/srote\/wp-json\/wp\/v2\/posts\/5789\/revisions"}],"predecessor-version":[{"id":5791,"href":"https:\/\/www.srotefeatures.in\/srote\/wp-json\/wp\/v2\/posts\/5789\/revisions\/5791"}],"wp:attachment":[{"href":"https:\/\/www.srotefeatures.in\/srote\/wp-json\/wp\/v2\/media?parent=5789"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.srotefeatures.in\/srote\/wp-json\/wp\/v2\/categories?post=5789"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.srotefeatures.in\/srote\/wp-json\/wp\/v2\/tags?post=5789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}